Vorinostat (SAHA, MK0683)

目录号：S1047 别名： SAHA, MK0683, suberoylanilide hydroxamic acid

Vorinostat (SAHA, MK0683) Chemical Structure

Molecular Weight(MW): 264.3

Vorinostat (suberoylanilide hydroxamic acid, SAHA)是一种HDAC抑制剂，无细胞试验中IC50为~10 nM。

规格 价格 库存 购买数量  
RMB 1558.77 现货
RMB 1198.15 现货
RMB 1794.86 现货
有超大折扣
大剂量询单有大折扣！

今日订购，明日送达，全国免运费！

全国免费电话：400-668-6834   |   Email：info@selleck.cn

客户使用Selleck该产品发表文献104篇：

客户使用该产品的20个实验数据：

  • Activity of vorinostat in Jurkat and Peer T-ALL cell lines in an MTT cell viability assay. Cells were treated with increasing drug concentrations for 72 h. The data are plotted as the mean % of DMSO-treated control cells against the corresponding drug concentration. The error bars are the standard error. For each drug and cell line, 3-4 independent experiments were performed with 6 replicates at each drug concentration.

    Nature 2011 471, 235-9. Vorinostat (SAHA, MK0683) purchased from Selleck.

    Differential effects of HDAC inhibitors on histone and tubulin acetylation. Immunofluorescence analysis of histone H3 (K9ac/K14ac) and tubulin acetylation in HeLa cells treated for 4 h with vehicle, SAHA (10 μM), tacedinaline (50 μM), PCI-24781 (20 μM. (a) Mapping of histone acetylation in K562 cells treated with HDAC inhibitors by LC-MS/MS. Cells were treated with TSA (10 μM), SAHA (5 μM), PCI-24781 (2 μM), tacedinaline (50 μM) for 6 h. Histones were extracted from cells and acetylated peptides were quantified after isobaric tagging.

    Nat Biotechnol 2011 29, 255-265. Vorinostat (SAHA, MK0683) purchased from Selleck.

  • Western blot analysis of histone H3 acetylation in the spleen of untreated and vorinostat-treated hNF-E2 tg mice (n = 4 of each genotype).

    J Exp Med 2012 209, 35-50. Vorinostat (SAHA, MK0683) purchased from Selleck.

    SAHA down-regulates c-FLIP expression and increases the sensitivity of CaP cells to undergo apoptosis in the presence of bicalutamide (A) Bar graph illustrating the sub-G0/G1 cell population in 22Rv1 (left panel) and LNCaP (right panel) cells in the absence and presence of 10μM bicalutamide, administered as a single agent or in ombination with increasing concentrations of the HDAC inhibitor, SAHA. (B) Immunoblots demonstrating the single agent activity of bicalutamide or SAHA, or effect upon their combined administration on the expression of c-FLIP and/or the processing of PARP. Equal protein loading was confirmed by GAPDH. (C) Bar graph illustrating the effect of bicalutamide and SAHA upon the induction of caspase-8 or caspase-3/7 activity in 22Rv1 cells (left panel) and LNCaP cells (right panel). (D) Immunoblots characterizing the impact of SAHA and/or bicalutamide upon the induction of PARP cleavage, in the absence or presence of the pan-caspase inhibitor, ZIETD. ZIETD was incubated with the cells for 12 h prior to the experiment. All data points shown in (A) and (C) represent the mean ± S.E.M. value, calculated from four independent experiments.

    Clin Cancer Res 2012 18, 3822-33. Vorinostat (SAHA, MK0683) purchased from Selleck.

  • Analyses of efficacy, potency and IC50 of HDAC inhibitors point toward HDACs 1–3 as relevant candidates for beta cell protection. Ranking and raw data on ITF drugs (Table 3) and commercial HDAC inhibitors (Table 4) underlying the heat maps of Fig. 1 (A and B). The HDAC inhibitor compounds were tested using a HDAC activity kit and recombinant proteins to determine IC50 values on each individual HDAC (right part of the table). Each drug was further tested using Real-Time Cell Analysis (RTCA) to score their maximal effective concentration (ECmax) as well as the corresponding rescue percentage of cytokine treated INS-1 cells. The drugs were ranked according to % rescue. * DMSO alone controls were included in each experiment, but not shown here. The results indicate that the highest concentrations of DMSO used here (1:1,000) were slightly potentiating the proliferation of the cells. The effects observed in this group of compounds were ascribed to the DMSO.?

    Diabetologia 2012 55, 2421-2431. Vorinostat (SAHA, MK0683) purchased from Selleck.

    Suberoylanilide hydroxyamic acid (SAHA) preserves CFP (+) expression in mouse optic nerves (MONs) from older mice. (a) CFP (+) mitochondria were longer and thicker in MONs from 12-month-old Thy-1 CFP mice (inset; scale bar = 2 μm). Oxygen–glucose deprivation (OGD) consistently reduced CFP pixel intensity in 12-month-old MONs despite longer and brighter CFP ( +) mitochondria (yellow arrows). (b) Blockade of AMPA/kain ate receptors with NBQX (30 μM), or pan-Histone deacetylase (HDAC) inhibition with SAHA (5 μM), effectively preserved CFP pixel intensity during OGD. The preservation of CFP (+) mitochondria correlates with protection of the CAP area during OGD and profound recovery.

    J Neurochem 2012 123 Suppl 2, 108-15. Vorinostat (SAHA, MK0683) purchased from Selleck.

  • D and E, Regression of IL-13Ra 2-negative pancreatic tumors treated with SAHA and/or IL-13-PE. Mice were treated daily with i.p. injection of SAHA (25 mg/kg) from day 4 after tumor implantation for two weeks followed by i.t. injection of IL-13-PE (100 μ g/kg) from day 5 for two weeks. F and G, Regression of IL-13Ra 2-posotive pancreatic tumors (HS766T and MIA-PaCa2) treated with SAHA and/or IL-13-PE. The schedule of treatment was similar as in panel D and E. Statistical significances are shown by *: P < 0.05,†: P < 0.001.

    J Transl Med 2011 9, 37. Vorinostat (SAHA, MK0683) purchased from Selleck.

    IL-13Rα2 expression is upregulated in pancreatic tumors but not in organs of mice after treatment with HDAC inhibi tor, SAHA. A, qRT-PCR of human IL-13Rα2 in implanted pancreatic tumors after SAHA and IL-13-PE treatment. Tumors were harvested next day after IL-13-PE treatment and total RNA extracted. Data shown is ratio of human IL-13Rα2/β-actin expression and multiplied by 1000 for convenience. Bars , SD of triplicate determinations. B, qRT-PCR of mouse IL-13Rα2 in mice organs after SAHA and IL-13-PE treatment. Tissues were harvested at the same time point as in panel A and total RNA extracted. Data shown is ratio of mouse IL-13Rα2/β-actin expression and multiplied by 100 for convenience. C, IHC of human IL-13Rα2 in implanted pancreatic tumors after SAHA and IL-13-PE treatment. D, IHC of mouse IL-13Rα2 in mice organs after SAHA and IL-13-PE treatment. Liver, brain, kidney, pancreas, lung and spleen were fixed for immunostaining of mouse IL-13Rα2 as visualized by Alexa555. Nucleus was counterstained by DAPI.

    J Transl Med 2011 9, 37. Vorinostat (SAHA, MK0683) purchased from Selleck.

  • Proliferation o f HT29 and HCT116 cells after 48 h of butyrate or SAHA treatment. Proliferation measurements using the xCEL Ligence RTCA DP instrument (Roche) in cells treated with increasing doses of butyrate or SAHA, compared with control medium cells (0) (*P < 0.05). The mean ?SEM of three cell culture replicates is shown.

    Mol Carcinog 2012 52, 459-74. Vorinostat (SAHA, MK0683) purchased from Selleck.

    SAHA induces the down-regulation of cFLIP expression and promotes TRAIL-mediated activation of a mitochondrial-operated apoptotic pathway. a BT-474 cells were treated as indicated in Fig. 1 and the cells were then harvested to analyse caspase-8, Bid, caspase-9, caspase-3 and PARP expression, using GAPDH as the protein loading control. b BT-474 cells were treated with SAHA for 8 h at the doses indicated and subsequently, the cells were harvested and the apoptosis-related proteins were analysed in western blots as described in the "Materials and Methods". The results shown are representative of at least three independent experiments

    Invest New Drugs 2012 30, 541-547. Vorinostat (SAHA, MK0683) purchased from Selleck.

  • Treatment with SAHA sensitizes breast cancer cells to TRAILinduced apoptosis. BT-474 and MDA-MB-231 cells were incubated for 8 h with SAHA at the doses indicated. After this time, TRAIL (500 ng/ml) was added to some of the cultures for an additional 15 h. Apoptosis was measured as the percentage of cells with subG1 DNA content as described in the "Materials and methods". The results show the mean and S.E.M. of three independent experiments

    Invest New Drugs 2012 30, 541-547. Vorinostat (SAHA, MK0683) purchased from Selleck.

    SAHA facilitates the Itch/AIP4-independent proteasomal degradation of cFLIP proteins in breast cancer cells. a BT-474 cells were treated with SAHA (5 μM) for 8 h in the presence or absence of the proteasome inhibitors MG132 or epoxomicin (at the doses indicated), and they were then harvested and the cFLIP content was analysed in western blots. b BT-474 cells were transfected with either the siRNA oligonucleotides targeting Itch/AIP4 or the non-targeting RNA oligonucleotide (scrambled) for 48 h as described in the "Materials and Methods". Subsequently, the cells were treated with SAHA (5 μM) for 8 h and then cFLIP and Itch/AIP4 expression was analysed in immunoblots

    Invest New Drugs 2012 30, 541-547. Vorinostat (SAHA, MK0683) purchased from Selleck.

  • cFLIP down-regulation following SAHA treatment is responsible for the sensitization of breast cancer cells to TRAIL. a BT-474 cells were transfected with either different siRNAs directed against the cFLIP isoforms or the non-targeting RNA oligonucleotide (scrambled) as described in the "Materials and Methods". After 24 h, the cells were treated with TRAIL (500 ng/ml) for a further 15 h and apoptosis was then measured as the percentage of cells with subG1 DNA content. The results show the mean and S.E.M. of three independent experiments. To verify protein knockdown, cells were harvested 24 h after transfection and the cFLIP levels were assessed in immunoblots. b. BT-474 cells overexpressing Cflipl (pBABE-FLIPL) or control cells (pBABE) were treated with SAHA for 8 h at the doses indicated. After this time, TRAIL (500 ng/ml) was added to some cultures for 15 h. Apoptosis was measured as the percentage of cells with subG1 DNA content and the results show the mean and range of two independent experiments. Western blots show the cFLIP levels after SAHA treatment in pBABE and pBABE-FLIPL cells.

    Invest New Drugs 2012 30, 541-547. Vorinostat (SAHA, MK0683) purchased from Selleck.

    Vorinostat inhibits the tumor growth. NOD ⁄ SCID-B2m-/-mice were injected s.c. with 1×106 MyLa2059 cells into both flanks. When the mice had developed established palpable tumors treatment was initiated (day 1). The mice received either vehicle (black line) or 60 mg ⁄ kg vorinostat (grey line) i.p. five days a week. In total, there were four mice in the group receiving vehicle and three mice in the group receiving vorinostat. The length and width of the tumors were measured continuously until the experiment was terminated on day 20 post treatment initiation. The tumor volume was calculated using the formula V = (a×b2)/2, where a defines the length (mm) and b the width (mm) of the tumor. The histogram shows the average tumor volume per flank ± SEM. * denotes a significant difference (P < 0.05) in the average tumor volume per flank between mice treated with vehicle and vorinostat at the given time-point both by using a one-tailed two samples test with Welch, scorrection and a Mann-Whitney U test.

     

     

    Exp Dermatol 2010 19, 1096-1102. Vorinostat (SAHA, MK0683) purchased from Selleck.

  • (a) Western blot of whole cell extracts demonstrates SAHA and NaB treatment result in increased levels of acetylated histone H3 compared to vehicle controls. (b) Light micrographs of HDACi/vehicle treated cultures illustrate the paucity of neurospheres in HDACi-treated cultures. (c) Quantitative analysis confirms SAHA and NaB inhibit the formation of neurospheres (diameter ≥ 50 μm) and increase the prevalence of small cell clusters (≥ 4 cell, diameter < 50 μm). (d) Flow cytometry using LIVE/DEAD cell stain confirms SAHA and NaB are minimally toxic compared to vehicle controls (n = 3). Scale bar = 100 μm.

    BMC Neurosci 2011 12, 50. Vorinostat (SAHA, MK0683) purchased from Selleck.

    (a) EdU flow cytometry of live cell-gated adult mouse NSCs demonstrates SAHA (**p < 0.01) and NaB (***p < 0.001) significantly inhibit DNA synthesis. (b) Analysis of DNA content by flow cytometry reveals significant accumulation of adult mouse NSCs in G1phase of the cell cycle following SAHA (*p < 0.05) and NaB (*p < 0.05) treatment. (c) Correspondingly the proportion of cells in G2/M phase is significantly reduced following SAHA (*p < 0.05) and NaB (*p < 0.05) treatment. (d) Fluorescence micrographs of HDACi/vehicle treated adult NSCs pulse-labeled with EdU for flow cytometry. Scale bar = 50 μm. Statistical comparisons performed using one-way ANOVA with post hoc Newman-Keuls multiple comparison tests.

    BMC Neurosci 2011 12, 50. Vorinostat (SAHA, MK0683) purchased from Selleck.

  • (a) Immunofluorescence labeling of NeuN, GFAP and Olig2 cell fate markers reveals reduced expression of GFAP (*p < 0.001) and Olig2 (*p < 0.05) in adult mouse NSCs treated with SAHA for 48 hours under proliferation culture conditions and then induced to differentiate for 14 days in culture (two-way ANOVA with Bonferroni post-tests). (b) Western blot of β-catenin protein in nuclear and cytoplasmic fractions of adult mouse NSCs treated with HDACi/vehicle control under proliferation culture conditions. Gapdh and lamin A/C blots are included as loading controls. (c) SAHA and NaB do not significantly alter nuclear/cytoplasmic levels of β-catenin in adult mouse NSCs. Histogram of β-catenin Western blot signal intensities normalized to loading controls (n = 4).

    BMC Neurosci 2011 12, 50. Vorinostat (SAHA, MK0683) purchased from Selleck.

    Morphological changes and histone H3 phosphorylation of HB cells treated with a combination of VX-680 and SAHA. HUH6 and HepT1 were incubated with VX-680 (6 μM) and SAHA (0.5 μM). Nuclei diameter (a) and cell diameter (b) were determined 72 h later by DAPI staining and microscopy. Data represent mean±SD of the diameters from 20 cells in each experiment. (* Two-way ANOVA, Bonferroni test, p \0.05). c Western blot analysis on HUH6 and HepT1 cells were carried out with an anti-phospho-Histone H3 (Ser 10) antibody (p-H3) 24 h after incubation with VX-680 (10 μM), SAHA (0.2 μM) or a combination of both. Controls were left untreated. Western blot analysis showed a decrease in p–H3 after treatment with VX-680 ( lane 2 ) relative to controls ( lane 1 ) and an increase when SAHA was added ( lane 3 ). For the combination of VX-680 and SAHA (lane 4 ) no p-H3 was detected.

    Pediatr Surg Int 2012 28, 579-89. Vorinostat (SAHA, MK0683) purchased from Selleck.

  • Vorinostat promotes C2C12 differentiation.In the image, the red is the myotube indicating differentiation ,the blue is the nuclei.

     

     

    Dr. Akihiko Yoshimura of Akihiko Yoshimura. Vorinostat (SAHA, MK0683) purchased from Selleck.

    Western blot analysis of Acetyl-H3 and H3. 0-20μM SAHA was added.

     

     

    Dr. Zhang of Tianjin Medical University. Vorinostat (SAHA, MK0683) purchased from Selleck.

产品安全说明书

HDAC抑制剂选择性比较

生物活性

产品描述 Vorinostat (suberoylanilide hydroxamic acid, SAHA)是一种HDAC抑制剂，无细胞试验中IC50为~10 nM。
特性 Vorinostat是广谱HDAC活性抑制剂，抑制I和II类酶 。
靶点
HDAC [1]
(Cell-free assay)
~10 nM
体外研究

Vorinostat是小分子量（<300）线性肟酸，抑制HDAC活性，包括乙酰化组蛋白和非组蛋白的积累，抑制培养细胞的增殖，且抑制肿瘤生长。Vorinostat通过结合到酶的活性位点而抑制 HDAC活性。Vorinostat 抑制多种转化细胞增殖（包括 淋巴瘤，多发性骨髓瘤，白血病，和非小细胞肺癌），与对照组相比抑制生长达50% 时的浓度为0.5 到10μM。Vorinostat作用于淋巴瘤和白血病细胞，包括 Burkitt, B-细胞急性淋巴细胞白血病 (B-ALL), MCL, DLBCL, ATL和T-细胞，不同程度抑制细胞增殖。除了抑制转化细胞增殖, Vorinostat 也抑制正常细胞增殖，通过比较Vorinostat 作用于一组细胞系–正常人非纤维细胞(WI-38)和 SV40巨大T抗原转化WI-38(VA-13细胞)而得到证明。Vorinostat 抑制两种类型细胞增殖，这种作用存在剂量依赖性。但发现Vorinostat 对转化细胞具有选择毒性，包括使肿瘤细胞死亡，而对正常细胞只起抑制作用，不会使其死亡。[1] Genistein 和Vorinostat 联用效果比5-aza和Vorinostat 联用作用于诱导细胞死亡有效很多。Genistein和Vorinostat联用作用于ARCaP-E使增殖降低 80 %，作用于ARCaP-M细胞，增殖降低60 %以上。Genistein和Vorinostat 联用抑制细胞增殖具有协同效应。作用于ARCaP-E 细胞(820个基因 诱导和1046个基因抑制) ARCaP-M 细胞，Vorinostat比Genistein 影响更多基因。[2] Vorinostat作用于肿瘤细胞表面，提高Fas蛋白水平，这种作用存在剂量依赖性，且按0.75 μM剂量处理，提高达到一个稳定水平。[3] Vorinostat 抑制肿瘤细胞生长，包括NB4, H460 和HCT-116，IC50分别为0.7μM, 3.4μM和1.2 μM。[4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
A20 M1v3VGtqdmG|ZTDBd5NigQ>? M{Xq[lEhcA>? MoLiSG1UVw>? Mme4ZY51cS2KRFHDNUBi[3Srdnn0fUB4cXSqIFnDOVAhd2ZiMD6xNVIh|ryP MnPxNVE6PjB2OEm=
Friend leukemic cell Mk\FS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXywOWtRPTBizszN MXy3NkBp NXSzPGdMTE2VTx?= NGO4[VZKSzVyPUCuPVkh|ryP NUHocnQ{OTJzMEm5NVM>
K562 NWXwbnZnU2mwYYPlJGF{e2G7 Moj2OkBp Mm\4SG1UVw>? MXzJcohq[mm2aX;uJI9nKGi3bXHuJIhqe3SxbnWg[IVi[2W2eXzhd4UhMG2reIT1doUhd2ZiSFTBR|Eh[W6mIFjERWMzMSC5aYToJGlEPTBib3[gNE4xOSEQvF2= MX2xNlQyQTN6MB?=
HT1080 NYTXUnRyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXm3NkBp NE\r[mtFVVOR NHrydmhKSzVyPUKuOEDPxE1? MlPmNVIzPzBzN{W=
H1299 MU\LbY5ie2ViQYPzZZk> NFHXRpkzOCCvaX6= MXLEUXNQ NYf1XJREUW6qaXLpeI9zgSCjY4Tpeol1gSCjZ3HpcpN1KEiGQVOg[Y57gW2nIIfpeIghUUN3MDDv[kAxNjF7NDFOwG0> Mmq5NVQ2OjF2MkK=
H1299 MofFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEfQdlE4OiCq M{joWmROW09? M2i4WGlEPTB;Nz6yOEDPxE1? NYT1ZYt6OTR3MkG0NlI>
HeLa MljxT4lv[XOnIFHzd4F6 NWrUeZliOzBibXnu M1K4RWlvcGmkaYTvdpkh[2:wY3XueJJifGmxbjDh[4FqdnO2IHjpd5RwdmViZHXhZ4V1gWyjc3Wge4l1cCCLQ{WwJI9nKDBwMkig{txO MV[xOVYxOzl2OR?=
LOX-IMVI NUSzUWZGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF73fGE1QCCq M4Tzb2lEPTB;MT6zJO69VQ>? MoTHNVU4OTV2N{C=
NCI-H226 MlzES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MU[0PEBp NYX2TplIUUN3ME2yMlYh|ryP M3P1bFE2PzF3NEew
RXF-631L NWCze4pyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWG0PEBp MlPGTWM2OD1{IN88US=> MVyxOVcyPTR5MB?=
SNB-78 MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mmj4OFghcA>? NVnSdWhZUUN3ME2xOkDPxE1? MV2xOVcyPTR5MB?=
St-4 NFzrPWFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{D1SlQ5KGh? MlTVTWM2OD13LkKg{txO NFjtU5kyPTdzNUS3NC=>
ARP1 NWP1Tod{TnWwY4Tpc44hSXO|YYm= M1zFZVIh|ryP M3zteFYhcA>? MnywTY5lfWO2aX;uJI9nKFB{MWfBSlEh\2WwZTDlfJBz\XO|aX;u NFv1cHgyPDd|NEiwOi=>
CEM NFPQN2VMcW6jc3WgRZN{[Xl? NXjBb|FmOSCq NWHUUI1jTE2VTx?= NHPIbYNKdmirYnn0bY9vKG:oIFjERWMhf2m2aDDJR|UxKG:oIECuN|Mh|ryP NFfJUW8yPjR{MEC2OC=>
HCT15 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUnCcXpCPDhiaB?= MVPHTVUxRTBwOEKg{txO Ml\ONVY4OjN{Mke=
NCI-H23 Mn7MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4DXW|Q5KGh? MmrQS2k2OD1yLkmyJO69VQ>? NEPVWG4yPjd{M{KyOy=>
GM15850 NIrVUWJMcW6jc3WgRZN{[Xl? NWLPUI5oOi53IN88US=> NI\XcHA6PiCq NIDIbphFVVOR MY\Jcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iaHnzeI9v\SCKMzDsfZNqdmViMUSgZYNmfHmuYYTpc44hd2ZiRmjOJIdmdmV? NUXYfIpYOTZ7MkGzOlc>
GM15850 NIC4R4NMcW6jc3WgRZN{[Xl? MnLXNk42KM7:TR?= MXG5OkBp NEm0VmhFVVOR NY[yVlVQUW6qaXLpeIlwdiCxZjDISGFEKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFQhdHm|aX7lJFUh[WOndInsZZRqd25ib3[gSnhPKGenbnW= M1zlWVE3QTJzM{[3
GM15850 M1\pS2tqdmG|ZTDBd5NigQ>? NVKxW2dzOi53IN88US=> M33Kdlk3KGh? NIDJNIdFVVOR MXvJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iaHnzeI9v\SCKNDDsfZNqdmViMUKgZYNmfHmuYYTpc44hd2ZiRmjOJIdmdmV? NVGxNXM6OTZ7MkGzOlc>
GM15850 MXfLbY5ie2ViQYPzZZk> NVHHSWQ1Oi53IN88US=> MmXsPVYhcA>? NFX0RVhFVVOR NXjkTYlKUW6qaXLpeIlwdiCxZjDISGFEKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFMhdHm|aX7lJFkh[WOndInsZZRqd25ib3[gSnhPKGenbnW= NXzhfWQ2OTZ7MkGzOlc>
GM15850 MXLLbY5ie2ViQYPzZZk> NIP0dlYzNjVizszN MXG5OkBp MVfEUXNQ NYf6doNsUW6qaXLpeIlwdiCxZjDISGFEKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFQhdHm|aX7lJFgh[WOndInsZZRqd25ib3[gSnhPKGenbnW= NWGyXpZrOTZ7MkGzOlc>
GM15850 MlnXT4lv[XOnIFHzd4F6 NXP0VlFIOi53IN88US=> NGfpRmc6PiCq MWLEUXNQ M2q2VWlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDobZN1d26nIFi0JIx6e2mwZTCxOkBi[2W2eXzheIlwdiCxZjDGXG4h\2WwZR?= MUWxOlkzOTN4Nx?=
U937 M3[xVWZ2dmO2aX;uJGF{e2G7 MVe1JO69VQ>? MUSyOEBp MVjEUXNQ MUfD[YxtKGO7Y3zlJIFzemW|dDDifUBi[2O3bYXsZZRqd25iYYSgV{9IOi:PIIDoZZNm MX6xO|AxPDdzOB?=
H661 M3vsWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVu0PEBp NYL3dI9GUUN3ME2xJO69VQ>? MmW3NVcyPTdyMEm=
U937 MnyzSpVv[3Srb36gRZN{[Xl? NF32eJU2KM7:TR?= NWHpTJJzOjRiaB?= NHTGdmNFVVOR NF\Wdm1KdmO{ZXHz[UBqdiCqaYP0c45mKEh|IHHj[ZR6dGG2aX;u NYrJSWVrOTd2NEe3OVA>
U937 MlXNSpVv[3Srb36gRZN{[Xl? MYOxJO69VQ>? NEnOeW0zPCCq M4LFemROW09? M1LKUmVn\mWldDDvckBidHCqYTD0eYJ2dGmwIHHj[ZR6dGG2aX;u MoD5NVc1PDd5NUC=
RAW264.7 MWHGeY5kfGmxbjDBd5NigQ>? NFHNfJQyOCEQvF2= MoDmNlRp MlrPe4F1\XJ? NXLMTnhJUW6qaXLpeIlwdiCxZjDMVHMue3SrbYXsZZRm\CCWTl\hcJBp[SCycn;keYN1cW:wIIfpeIghUUN3MDDv[kAxNjd4IN88US=> M2\GNVE4PDd5NUG4
RAW264.7 MoHBSpVv[3Srb36gRZN{[Xl? NEHpcYkyOCEQvF2= MUWyOIg> NX;jT5puf2G2ZYK= M2m2XmlvcGmkaYTpc44hd2ZiTGDTMZN1cW23bHH0[YQhVk9icILv[JVkfGmxbjD3bZRpKEmFNUCgc4YhOS56ODFOwG0> MXmxO|Q4PzVzOB?=
SC9 NXH4SppWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXnWZZdqPDhiaB?= NXjnTYl{UUN3ME2wMlYxPiEQvF2= MWCxO|UxPzJzOR?=
ST14A M2DGdGZ2dmO2aX;uJGF{e2G7 M3zCblUhdk1? NYfJ[JlkPzJiaB?= Mn7NTY5kemWjc3WgbY4hWkWVVD;OVnNHKG2UTlGg[ZhxemW|c3nvci=> NVjHVI5mOTd3NkW5PVM>
ST14A NHq1O5pHfW6ldHnvckBCe3OjeR?= MVO1JI5O M4L3Z|czKGh? NYHVc4JlUW6lcnXhd4UhcW5iRULGNUBuWk6DIHX4dJJme3Orb36= NGro[XYyPzV4NUm5Ny=>
PANC1 NXmzXI03T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV3re5pjOSEQvF2= MkLrTWM2OD1yLkS1JO69VQ>? NUnXR|VmOTd3OEi3OFQ>
PANC1 NInNUIRHfW6ldHnvckBCe3OjeR?= NYPufmVKOSEQvF2= NXHoN4F5OjRiaB?= MWXJcoNz\WG|ZTDpckBxOjGZQV[xM2NKWDFiZ3Xu[UBmgHC{ZYPzbY9v NWXYdVVXOTd3OEi3OFQ>
PANC1 MXLGeY5kfGmxbjDBd5NigQ>? NV63N4E5OSEQvF2= MXKyOEBp MlHnTY5kemWjc3WgbY4heDJ5a3nwNUBo\W6nIHX4dJJme3Orb36= M4HFOVE4PTh6N{S0
PT45 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYrJR|UxRTRizszN NVTPT45DOTd3OEi3OFQ>
ACHN NXnSfpQ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4POO|IyKGh? M{HQdWdKPTB;MD62OUDPxE1? M13HeVE4PjZ{NkC2
PC3 NWrTVHJkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUn2PW1wOjFiaB?= MVHHTVUxRTBwN{Gg{txO Mn\jNVc3PjJ4ME[=
A431 NV;P[JZCS3m2b4TvfIlkKEG|c3H5 MojSO|IhcA>? MoTrTWM2OD12LkKg{txO MWCxO|Y6OTd4Mx?=
Cal27 MXvDfZRwfG:6aXOgRZN{[Xl? M4DSR|czKGh? MULJR|UxRTNwMjFOwG0> MkPiNVc3QTF5NkO=
CCRF-CEM NVzPdVF7S3m2b4TvfIlkKEG|c3H5 M3nHOFczKGh? NGnXXXdKSzVyPUCuPEDPxE1? NVH3Z|AzOTd4OUG3OlM>
EOL1 NU\LZ4Y1S3m2b4TvfIlkKEG|c3H5 MVS3NkBp M{LrWGlEPTB;MTFOwG0> Ml7DNVc3QTF5NkO=
Hec-1-A NHTVXoNEgXSxdH;4bYMhSXO|YYm= MnzIO|IhcA>? NGrEe2RKSzVyPUGg{txO NH7LTZYyPzZ7MUe2Ny=>
HeLa MY\LbY5ie2ViQYPzZZk> MmK1NVAh|ryP MoLnN|AhdWmw M12x[GROW09? MXnJcohq[mm2aX;uJI9nKHKnY3;tZolv[W62IFjERWMyKHerdHigTWM2OCCxZjCwMlAzKM7:TR?= MljPNVc3QTF5NkO=
RKOp21 M2LIPGN6fG:2b4jpZ{BCe3OjeR?= M3HpS|czKGh? MoHQTWM2OD1zLke2JO69VQ>? NW[xdZNWOTd4OUG3OlM>
Saos2 MX7DfZRwfG:6aXOgRZN{[Xl? NG\Dc3U4OiCq MkX1TWM2OD1{LkOg{txO MWqxO|Y6OTd4Mx?=
SK-OV-3 M1r5[mN6fG:2b4jpZ{BCe3OjeR?= M1qzdFczKGh? M{juTmlEPTB;Mj6yJO69VQ>? NVmzZ5RKOTd4OUG3OlM>
U87MG MYfDfZRwfG:6aXOgRZN{[Xl? M{jlUFczKGh? MkDYTWM2OD1zMTFOwG0> NYPqU2g1OTd4OUG3OlM>
NUGC3 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWS1JO69VQ>? MVSyOEBp MUXHTVUxRTJwN{mg{txO MXmxO|kxPDh2Mx?=
CCD1059SK NV\mdZozT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFztSXVKSzVyPUSzMlUh|ryP NH7GUZIyQDJ2N{W1OC=>
HepG2 M4HYOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoG2TWM2OD1yLkCwNFYh|ryP NYrTU21uOTh{NEe1OVQ>
HT1080 NYLnZpZFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYTJR|UxRTBwMECyOEDPxE1? NUjOTZBLOTh{NEe1OVQ>
SKBR3 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2HKe2lEPTB;MD64JO69VQ>? M3HxUVE5OjR5NUW0
SNB78 M{DhXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NU[5cnk6TUN3ME2xOkDPxE1? MYOxPFI1PzV3NB?=
SQ20B NYrUZ3BXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHy0N2FKSzVyPUOg{txO MV[xPFI1PzV3NB?=
St4 M2XlN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGjJepBGSzVyPUWuNkDPxE1? M4L6VVE5OjR5NUW0
MCF7 MojRSpVv[3Srb36gRZN{[Xl? M3nZd|ExKM7:TR?= NET3[2o5KGh? MnLlSG1UVw>? MV\JcoR2[3Srb36gc4YhfHWkdXzpckBpgXCncnHj[ZR6dGG2aX;u MX6xPFI3QTJ{Nh?=
HEK293 MoPyT4lv[XOnIFHzd4F6 MojqNUBp MX3EUXNQ NFHwfolKdmirYnn0bY9vKG:oIFjERWMyKHerdHigTWM2OCCxZjCwMlA{KM7:TR?= NFOwNWUyQDNyOEW2Ny=>
HEK293 MmLRT4lv[XOnIFHzd4F6 M2nZOVEhcA>? MWjEUXNQ NVPsS5ZRUW6qaXLpeIlwdiCxZjDISGFEOyC5aYToJGlEPTBib3[gNE4xPTdizszN MojGNVg{ODh3NkO=
G401 M{PMUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUO3NkBp NIDI[pNFVVOR MX;JR|UxRTFizszN MV6xPFM4ODN5Mx?=
HeLa NHHkU4hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3zPR|czKGh? MkDSSG1UVw>? MmT2TWM2OD1yLkS2JO69VQ>? NWHh[4JPOTh|N{CzO|M>
Human renal epithelial cell M1f3fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml3jO|IhcA>? Mn71SG1UVw>? NX74VJRzUUN3ME2xOEDPxE1? M4joPVE5OzdyM{ez
U937 M4nZPWZ2dmO2aX;uJGF{e2G7 MUO1JO69VQ>? MV2yOEBp M4jPUmlv\HWldHnvckBw\iCqaYP0c45mKEh2IHj5dIVz[WOndInsZZRqd25? NUO4O2UxOTh|OEGyN|g>
U937 NUXOeXA3TnWwY4Tpc44hSXO|YYm= MV61JO69VQ>? NH\EZ4gzPCCq MlHLTY5lfWO2aX;uJI9nKGGucHjhJJR2[nWuaX6gbJlx\XKjY3X0fYxifGmxbh?= MXSxPFM5OTJ|OB?=
U937 Ml;QSpVv[3Srb36gRZN{[Xl? NWPCSnJGPSEQvF2= NXziR41QOjRiaB?= NVn5W21oUW6mdXP0bY9vKG:oIICyNUBmgHC{ZYPzbY9v NHTLdnMyQDN6MUKzPC=>
U937 NG\B[4FHfW6ldHnvckBCe3OjeR?= MkC1OUDPxE1? MkTUNlQhcA>? NGH6SmVKdmS3Y4Tpc44hd2ZiYYDvdJRwe2m| MWSxPFM5OTJ|OB?=
U937 MVTGeY5kfGmxbjDBd5NigQ>? MVu1JO69VQ>? MmHWNlQhcA>? M1GzcGlv\HWldHnvckBw\iCpcnHueYxw[3m2aXOg[Iln\mW{ZX70bYF1cW:w NV[yPIFpOTh|OEGyN|g>
U937 M1T3WmtqdmG|ZTDBd5NigQ>? NW\RZ5VNPSEQvF2= NXHD[HQxOjRiaB?= M2KwUmlvcGmkaYTpc44hd2ZiaIXtZY4hUESDQ{G= MmnPNVg{QDF{M{i=
U937 MoXOT4lv[XOnIFHzd4F6 MnfhOUDPxE1? M{PTZVI1KGh? MY\Jcohq[mm2aX;uJI9nKGi3bXHuJGhFSUN2 M{TaTVE5OzhzMkO4
HEK-TE M3PUUGZ2dmO2aX;uJGF{e2G7 MkPzOUDPxE1? NIXFXVA3cA>? NIr6blZFVVOR NUDITIN2UW6lcnXhd4UhcW5iaHnzeI9v\SCKMzDhZ4V1gWyjdHnvci=> NGP2RWMyQDR|NEG0OC=>
HPDE6c7 MmPKR5l1d3SxeHnjJGF{e2G7 NF7YPHU2OCEQvF2= NYXpdlhHPzJiaB?= MYnEUXNQ NHPpS2dKSzVyPUGuN{DPxE1? NUD3[FRTOTh2OUS0OlM>
Human microvascular epithelial cell M2f1eGN6fG:2b4jpZ{BCe3OjeR?= M{WyOlUxKM7:TR?= NX;XfIo5PzJiaB?= NV\lSFg{TE2VTx?= M4TXdmlEPTB;MT6zJO69VQ>? MWmxPFQ6PDR4Mx?=
Hup T3 M2j2NmN6fG:2b4jpZ{BCe3OjeR?= MYe1NEDPxE1? NX:5WYVzPzKq NI\lcWlFVVOR MXvJR|UxRTBwODFOwG0> M1H0VVE5PDl2NE[z
Mia Paca2 NEj1SYFEgXSxdH;4bYMhSXO|YYm= M{GyTVUxKM7:TR?= M1\3cFczcA>? M4fQfWROW09? NHn3NIJKSzVyPUGuNUDPxE1? M{CxWVE5PDl2NE[z
Panc 04.03 MkTUR5l1d3SxeHnjJGF{e2G7 MnTKOVAh|ryP MXi3Nog> M4PTO2ROW09? NUntb|l4UUN3ME2xMlIh|ryP NIDZPFQyQDR7NES2Ny=>
SU 86.86 NVX6XoU5S3m2b4TvfIlkKEG|c3H5 NHHObFE2OCEQvF2= MXW3Nog> MUDEUXNQ NXrhTXRmUUN3ME2xMlMh|ryP MmTRNVg1QTR2NkO=
HEK293 NH7TUHFMcW6jc3WgRZN{[Xl? NWjWOoMzOyCq MnjiTY5pcWKrdHnvckBw\iC{ZXPvcYJqdmGwdDDISGFEPiCneIDy[ZN{cW:wIIfpeIghUUN3MDDv[kAxNjBzOTFOwG0> M{TBOlE5PTV6Nk[5
HeLa MkfWT4lv[XOnIFHzd4F6 M1PaNFIhcA>? M{TlNmlvcGmkaYTpc44hd2ZiboXjcIVieiCKRFHDJJdqfGhiSVO1NEBw\iByLkC4N{DPxE1? NVP0W5NzOTh3NUi2Olk>
RAW264.7 NFLuRpBHfW6ldHnvckBCe3OjeR?= MUiyJO69VQ>? MWGzMlUhcA>? MXjEUXNQ M3ywc2FvfGmvYXzhdolidCCjY4Tpeol1gSCjZ3HpcpN1KFCuYYPtc4RqfW1iZnHsZ4lx[XK3bTDpcoZm[3SnZDD3bZRpKEmFNUCgc4YhOC5zMTFOwG0> NHT6eYkyQDZ2NEm2PS=>
NB4 NETsN3Q1QGh? MX;EUXNQ NHvudJhKSzVyPUCuOkDPxE1? MYKxPFczOzN2OR?=
HEK293 M363dWZ2dmO2aX;uJGF{e2G7 Mm\TNVAh|ryP M{H0eVI1KGh? M4fGNWROW09? NGHDO4xC[3SrdnH0bY9vKG:oIH3veZNmKFewdEPhJJNq\26jbHnu[{BmgHC{ZYPz[YQ> M{\1[lE6ODJ{Nke1
HCT116 MmOwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF[xOG04Omh? NXLpUVlOTE2VTx?= NWXXVpBFUUN3ME2wMlMyKM7:TR?= M1:2eVE6ODh2Mkm0
HeLa M3rmU2tqdmG|ZTDBd5NigQ>? M4XJZ|Ih|ryP MnzlN|AhdWmw M3\DN2ROW09? MV;Jcohq[mm2aX;uJI9nKEiGQVOyJIlvKGi3bXHuJGhmVGFiY3XscJMhf2m2aDDJR|UxKG:oIECuNUDPxE1? M1H6NVE6ODh2Mkm0
IGROV1 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH;xWXQ4OiCq MXXEUXNQ MWrJR|UxRTJwMjFOwG0> NYDPfFlVOTlyOESyPVQ>
IGROV1 MlG4T4lv[XOnIFHzd4F6 NFPET5E2KM7:TR?= M4Ht[|I1KGh? M3q2XWROW09? MmfnTY5pcWKrdHnvckBw\iCKRFHDJIF{e2W|c3XkJIF{KHB3MzDhZ4V1gWyjdHnvci=> NEnhWXcyQTB6NEK5OC=>
IGROV1 MnXCT4lv[XOnIFHzd4F6 M1X4U|ExKM7:TR?= NWnxe2J5PCCq Mm\rSG1UVw>? MYnJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO|ZXSgZZMhcGm|dH;u[U1JPCCjY3X0fYxifGmxbh?= M33FXVE6ODh2Mkm0
IGROV1 NXjodW9yU2mwYYPlJGF{e2G7 MWCxNEDPxE1? MnfMOEBp MVzEUXNQ MU\Jcohq[mm2aX;uJI9nKEiGQVO2JIF{e2W|c3XkJIF{KGGucHjhMZR2[nWuaX6gZYNmfHmuYYTpc44> MnexNVkxQDR{OUS=
T24 NVyzTY5kU2mwYYPlJGF{e2G7 Mn3jN{Bp MmmzTY5lfWO2aX;uJI9nKGirc4TvcoUhUDNiYXPleJlt[XSrb36ge4l1cCCHQ{WwJI9nKDBwMUKg{txO NEHv[20yQTB6NEO5OS=>
T24 MkPKT4lv[XOnIFHzd4F6 MorQN{Bp M2X3Wmlv\HWldHnvckBw\iCjbIDoZUB1fWK3bHnuJIFk\XS7bHH0bY9vKHerdHigSWM2OCCxZjCwMlI2KM7:TR?= NUXleItqOTlyOESzPVU>
HeLa MYTLbY5ie2ViQYPzZZk> NUPtfXE{OTVibXnu M3LTRWROW09? NHfqOGtKdmirYnn0bY9vKG:oIFjERWM3KG[{b32gcpVkdGWjcjDlfJRz[WO2IIfpeIghUUN3MDDv[kAxNjB6NUWg{txO NXu4c|FpOTlyOUO4PFQ>
HeLa MlLXT4lv[XOnIFHzd4F6 MVixOUBucW5? MnjWSG1UVw>? M{H1TGlvcGmkaYTpc44hd2ZiSFTBR|gh\nKxbTDueYNt\WG{IHX4eJJi[3Rid3n0bEBKSzVyIH;mJFEvQDZizszN NET1bJMyQTB7M{i4OC=>
NCI-H69 NICwRW5EgXSxdH;4bYMhSXO|YYm= M4PPNFczKGh? MXTEUXNQ MULJR|UxRTJwME[g{txO NYLtU5VnOTlyOUO4PFQ>
SKMES1 M1\UcmN6fG:2b4jpZ{BCe3OjeR?= MWm3NkBp NYjrS3hnTE2VTx?= NF22N4VKSzVyPUKuOFIh|ryP MVOxPVA6Ozh6NB?=
S2 NXXXT5N7U2mwYYPlJGF{e2G7 MUewMlEuOTBizszN M{LNb|EhcA>? MoHNTY5pcWKrdHnvckBw\iCSbHHzcY9lcXWvIH\hcINqeGG{dX2gTGRCSzFiZYjwdoV{e2WmIIfpeIghUUN3MDDv[kAxNjB3OTFOwG0> MYWxPVMyPzR3MB?=
SHSY5Y MUTLbY5ie2ViQYPzZZk> MkjQNVAh|ryP NYmyToU4PDhiaB?= NGXpUJpFVVOR MknPTY5pcWKrdHnvckBw\iCKRFHDJJdqfGhiSVO1NEBw\iByLkWg{txO MWmxPVM1PDF5NR?=
SHSY5Y NEfob|BEgXSxdH;4bYMhSXO|YYm= NYXzfZoxOTBizszN MmnLOFghcA>? NWXQcY1nTE2VTx?= Mk\BTWM2OD1{IN88US=> NIHLWGIyQTN2NEG3OS=>
DMS114 M3fxd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGjncVc1QCCq M2jh[2dKPTB;Mj65JO69VQ>? MYKxPVQyQTJyNR?=
HBC5 NFr1VFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4PGXVQ5KGh? Ml\QS2k2OD1zNzFOwG0> NHq2NVEyQTRzOUKwOS=>
SNB78 NIfmN|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3j0ZlQ5KGh? NHS5cGlIUTVyPUG2JO69VQ>? MnmyNVk1OTl{MEW=
HeLa Mn\kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3f0W|czKGh? MoPpSG1UVw>? NGTVdmJKSzVyPUCuOFYh|ryP Ml\ENVk1PDF6NE[=
BHK NFTFdm1McW6jc3WgRZN{[Xl? MlPpOUDPxE1? NYSzNVRROjRiaB?= MXTEUXNQ Mny3TY5pcWKrdHnvckBw\iCKRFHDO{BmgHC{ZYPz[YQh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gdIxie22jIH3lcYJz[W6nIF\k[Yx1[TVyODDDSnRTKHC{b4TlbY4> NFLQeIcyQTl4Nke4PS=>
CFBE41o- NVPSSoVqU2mwYYPlJGF{e2G7 NV[yOpZnPSEQvF2= NVXYOo5iQCCq MWHEUXNQ MYjJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO|ZXSgZZMhcHmyZYLhZ4V1gWyjdHnvckBw\iCqaYP0c45mKEh| MVuxPVk3Pjd6OR?=
CFBE41o- MnPBT4lv[XOnIFHzd4F6 MYO1JO69VQ>? NYfiXGJjPCCq M1XRPWROW09? NUG0RnlkUW6qaXLpeIlwdiCxZjDISGFEKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJI12fGGwdDDG[IVtfGF3MEigR2ZVWiCycn;0[YlvKGyndnXs NH7lcHkyQTl4Nke4PS=>
CFBE41o- MnXjT4lv[XOnIFHzd4F6 NFnac4syKM7:TR?= MXexJIg> M1vybWROW09? MWnJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iQ1\UVkBxem:2ZXnuJIxmfmWu MUWxPVk3Pjd6OR?=
Primary bronchial epithelial cell M4\pVmtqdmG|ZTDBd5NigQ>? MVSxJO69VQ>? MV[yOEBp MkPTSG1UVw>? M3;sUGlvcGmkaYTpc44hd2ZiSFTBR|ch[XO|ZYPz[YQh[XNiaX7keYN1cW:wIH;mJI12fGGwdDDG[IVtfGF3MEigR2ZVWiCycn;0[YlvKGGyaXPhcEB{fXKoYXPlJIxw[2GuaYrheIlwdg>? NHLFU3oyQTl4Nke4PS=>
CFBE41o- NGryTGNMcW6jc3WgRZN{[Xl? MX6xJO69VQ>? NH7CZnY2KGSjeYO= MY\EUXNQ NWfRc4VUUW6qaXLpeIlwdiCxZjDISGFEPyCjc4Pld5Nm\CCjczDpcoNz\WG|ZTDpckB{fGGkaXzpfoF1cW:wIH;mJGZl\Wy2YUWwPEBETlSUIIDyc5RmcW5? M4PIO|E6QTZ4N{i5
CFBE41o- MWPLbY5ie2ViQYPzZZk> NWDJVHR2OSEQvF2= NXW5XnBkOjRiaB?= MVHEUXNQ MXvJcohq[mm2aX;uJI9nKEiGQVO3JIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIF\k[Yx1[TVyODDDSnRTKHC{b4TlbY4hfHKjZn\pZ4tqdmd? NVnIZWtiOTl7Nk[3PFk>
CFBE41o- M{DFcWtqdmG|ZTDBd5NigQ>? MYO1JO69VQ>? MljFNlQhcA>? MXfEUXNQ NFOxVWNKdmirYnn0bY9vKG:oIFjERWM4KGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJJJifGVib3[gcYF1fXKjdHnvckBw\iCFRmTSJJBzd3SnaX6geI8hcXS|IHfsfYNw\m:{bR?= MUixPVk3Pjd6OR?=
CFBE41o- MVfLbY5ie2ViQYPzZZk> NYPZcng5PSEQvF2= NWntWGlDOjRiaB?= NILWfVJFVVOR Mn\3TY5pcWKrdHnvckBw\iCKRFHDO{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDzeIFjcWyrdImgc4YhTmSnbIThOVA5KEOIVGKgdJJwfGWrbh?= NYDWOHp6OTl7Nk[3PFk>
CFBE41o- MV7LbY5ie2ViQYPzZZk> MXm1JO69VQ>? MVOyOEBp NV23cWxlTE2VTx?= M2DEfmlvcGmkaYTpc44hd2ZiSFTBR|ch[XO|ZYPz[YQh[XNiY3;ydoVkfGmxbjDv[kBufXSjboSgSoRmdHSjNUC4JGNHXFJidILh[oZq[2urbnegeI8h[2WubDDzeZJn[WOnIHHzJIdtgWOxZn;ycS=> MmPqNVk6PjZ5OEm=
Primary bronchial epithelial cell NXfoNmdFU2mwYYPlJGF{e2G7 NHX3cWc2KM7:TR?= NHvqemozPCCq MnjISG1UVw>? M3X2VWlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCrbnT1Z5Rqd25ib3[gcZV1[W62IF\k[Yx1[TVyODDDSnRTKHC{b4TlbY4h[XCrY3HsJJN2em[jY3WgcI9k[WyrenH0bY9v MoDZNVk6PjZ5OEm=
Primary bronchial epithelial cell NH;Qb5pMcW6jc3WgRZN{[Xl? NUfmcHdPOSEQvF2= MVO5OkBp MXfEUXNQ MULJcohq[mm2aX;uJI9nKEiGQVO3JIF{e2W|c3XkJIF{KGmwY4LlZZNmKGmwIIPoc5J1KGOrcnP1bZQh[3W{cnXueJM> NUP4[ow5OTl7Nk[3PFk>
BxPC3 M4\uWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGDEVmg4OiCq NYWxRo1jUUN3ME2yMlch|ryP NGK1[IkzODF2M{e3PC=>
CAL27 NUTE[5A1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYO3NkBp M3uz[GlEPTB;Mz63NkDPxE1? M{jzWlIxOTR|N{e4
Capan1 Mo\QS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXm3NkBp NHHiO5RKSzVyPUeuN{DPxE1? NF:xco0zODF2M{e3PC=>
HCC827 Mn75S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGjLblE4OiCq NUD6VJY1UUN3ME2xMlgh|ryP NIX1c4szODF2M{e3PC=>
LNCAP Mmj6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkfZO|IhcA>? NH31XlRKSzVyPUCuOVgh|ryP NF3z[lUzODF2M{e3PC=>
NCI-H2122 Mk\YS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUK3NkBp M4rQWGlEPTB;Nz61JO69VQ>? MXeyNFE1Ozd5OB?=
NCI-H358 MkDSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGPXXJg4OiCq MlnvTWM2OD1{LkWg{txO MYGyNFE1Ozd5OB?=
SCC15 MnG3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mor3O|IhcA>? NEHEN41KSzVyPUKuOFkh|ryP M3\QNlIxOTR|N{e4
SCC25 Mn;LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUG3NkBp MmrjTWM2OD1zLkmzJO69VQ>? MUGyNFE1Ozd5OB?=
SKHEP1 Mk\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX[3NkBp M3;RWGlEPTB;Mz60OkDPxE1? NGLOcFczODF2M{e3PC=>
BJ NIHMcXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVS0PGJsOTByIN88US=> M3XyclQ5KGh? NGfuUodFVVOR MkK1S5Jwf3SqIHnubIljcXSrb36gZZQhOC5yNTD0c{AyODBidV2= M3vVS|IxOTR|OESw
MUF M2TReWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4X2O|ExOCEQvF2= M2fxWlQ5KGh? NYfk[nl7TE2VTx?= MY\Hdo94fGhiaX7obYJqfGmxbjDheEAxNjB3IITvJFExOCC3TR?= M2T5d|IxOTR|OESw
Caco-2 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3zxNlExOCEQvF2= MVe0PIg> NYjuNGtZTE2VTx?= MWfJR|UxRThwMTFOwG0> M{e3SlIxOTR|OESw
Caco-2 MX3LbY5ie2ViQYPzZZk> NFHHeYM2KM7:TR?= MVy0JIg> MVXEUXNQ NH7QeJRKdmS3Y4Tpc44hd2ZiSFTBR{1u\WSrYYTl[EBpcXO2b37lJIFk\XS7bHH0bY9vKEmFNUCgc4YhOC5yM{eg{txO MVeyNFE1Ozh2MB?=
Caco-2 NXrJNpZ4U2mwYYPlJGF{e2G7 MXqwMlMyPiCwTTD0c{A{OS54IN88US=> NFiyeWg1KGh? M13UTGROW09? NXfyPWxHTXhidnn2c{BqdmirYnn0bY9vKG:oIHj1cYFvKEiGQVOxJJdqfGhiSVO1NEBw\iByLkGxPUDPxE1? M1HKWlIxOTR|OESw
Caco-2 M3rLPGtqdmG|ZTDBd5NigQ>? M4fWSlAvOzF4IH7NJJRwKDNzLk[g{txO MUG0JIg> Mmi2SG1UVw>? NYrIOYJMTXhidnn2c{BqdmirYnn0bY9vKG:oIHj1cYFvKEiGQVOzJJdqfGhiSVO1NEBw\iByLkG0O{DPxE1? M1PpR|IxOTR|OESw
Caco-2 NFjMVWZMcW6jc3WgRZN{[Xl? M3XGb|YvOzJibl2geI8hPjN{IN88US=> NWPUW494PCCq MWHEUXNQ NWrmZmVxTXhidnn2c{BqdmirYnn0bY9vKG:oIHj1cYFvKEiGQVO1JJdqfGhiSVO1NEBw\iBzMj62JO69VQ>? NWrtRZBQOjBzNEO4OFA>
Caco-2 NWPBNoJtU2mwYYPlJGF{e2G7 MnvBOk4{OiCwTTD0c{A3OzJizszN M2XES|QhcA>? M2\qSmROW09? NEjlbVdGgCC4aY\vJIlvcGmkaYTpc44hd2ZiaIXtZY4hUESDQ{ege4l1cCCLQ{WwJI9nKDRzIN88US=> MWWyNFE1Ozh2MB?=
Caco-2 M4j0PGtqdmG|ZTDBd5NigQ>? MlXBNE4{OTZibl2geI8hOzFwNjFOwG0> NWDpfndOPCCq NWLYRYJ4TE2VTx?= M3TZO2V5KH[rdn:gbY5pcWKrdHnvckBw\iCqdX3hckBJTEGFNh?= NXS1Vo1jOjBzNEO4OFA>
HepG2 NVHs[Gw2U2mwYYPlJGF{e2G7 M32wc|Uh|ryP MV[2bC=> NHixcoJFVVOR M4LITWlv\HWldHnvckBw\iCKRFHDMY1m\GmjdHXkJIhqe3SxbnWgZYNmfHmuYYTpc44> NUTJdHYyOjBzNEO4OFA>
HepG2 M1P0ZWtqdmG|ZTDBd5NigQ>? M4\j[|Uh|ryP MkHDOog> NYrFbXZ7TE2VTx?= MYDJcoR2[3Srb36gc4YhUESDQz3t[YRq[XSnZDDobZN1d26nIHj5dIVz[WOndInsZZRqd25? M{TYNlIxOTR|OESw
HepG2 NE\3ZmVMcW6jc3WgRZN{[Xl? M3vmcVUh|ryP Mn\qOog> NXTpXpBDTE2VTx?= NX;VNFROUW6mdXP0bY9vKG:oIFjERWMudWWmaXH0[YQh[WyyaHGteJVjfWyrbjDhZ4V1gWyjdHnvci=> M{PVbFIxOTR|OESw
HepG2 NELCSJNMcW6jc3WgRZN{[Xl? NULXVIdqPSEQvF2= Ml;3Oog> MVzEUXNQ M4HUVmlv\HWldHnvckBw\iCKRFHDMY1m\GmjdHXkJGg{N0h2IHjpd5RwdmViYXPleJlt[XSrb36= NEfmWo8zODF2M{i0NC=>
COLO205 NVjYTGpRU2mwYYPlJGF{e2G7 Ml20NVAh|ryP Mm\INlQhcA>? MmfOSG1UVw>? NYftc20yUW6qaXLpeIlwdiCxZjDISGFEOSCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4YhcGm|dH;u[UBJOyCjY3X0fYxifGmxbjD3bZRpKEmFNUCgc4YhOi5{IN88US=> Mm\wNlA1PTF|N{i=
SCC4 NELHOZhMcW6jc3WgRZN{[Xl? NXnsXZdkOSEQvF2= MoXHNlRp M3LqPGlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjD0eYJ2dGmwIHHj[ZR6dGG2aX;u NGftOWwzODR3MkKyOS=>
SCC4 NEe3R2pMcW6jc3WgRZN{[Xl? Mlz1NUDPxE1? M3TyTFI1cA>? NVTDR4VOUW6qaXLpeIlwdiCxZjDISGFEKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgZYNmfHmuYYTpc44> MnLtNlA1PTJ{MkW=
SCC4 NWfPNFBFTnWwY4Tpc44hSXO|YYm= NVvaeZdZOSEQvF2= M1XsV|UhdWmw MX\B[49vcXO2IHHjeIl3cXS7IHH0JHZFWiCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4YhS1mSMkSg[4Vv\SCneIDy[ZN{cW:w M4TEUlIxPDV{MkK1
NB4 MX7GeY5kfGmxbjDBd5NigQ>? M4fnbFUh|ryP NHzhN5IzPCCq NH\iflRFVVOR NFf0WmtE\WyuIHP5Z4xmKGG{cnXzeEBie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDhZ4N2dXWuYYTpc44h[XRicILlMWcyKHCqYYPl M3vWO|IxPDlzNESw
NB4 NYPRXJE1U2mwYYPlJGF{e2G7 M1HqPVUh|ryP M3TYUlI1KGh? Mly4SG1UVw>? MV3Jcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iYXPleJlt[XSnIIT1ZpVtcW5ibHX2[Yw> MofNNlA1QTF2NEC=
NB4 MkW4SpVv[3Srb36gRZN{[Xl? NX\jdlFnPSEQvF2= NXKzbYFYOjRiaB?= M3\tdGROW09? MYDJcoR2[3Srb36gc4YheDJzV1HGNU9EUVBzIHX4dJJme3Orb36= MXKyNFQ6OTR2MB?=
NB4 Mn65T4lv[XOnIFHzd4F6 NXf5d4llPSEQvF2= M4f6UFI1KGh? NXnrbldZTE2VTx?= NFrhVVJKdmirYnn0bY9vKG:oIFjERWMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gbIl{fG:wZTDIN{Bi[2W2eXzheIlwdg>? NGTyTWczODR7MUS0NC=>
NUGC3 M4PQRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV7wXFlrT0l3ME2yMlk1KM7:TR?= M3i1XlIxQDVyOUex
A549 NUGze5JYTnWwY4Tpc44hSXO|YYm= NWLDTZU6PSEQvF2= MVezJIg> MUHEUXNQ NFvUTGdKdmS3Y4Tpc44hd2ZiYYX0c5Bp[We7IHnuJIh2dWGwIFG1OFkh[2WubIOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iTFOzTWk> NFPWdmUzODh3NUKwPC=>
HUT78 NV:xSVB7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXr5Vow{PzJiaB?= MlLaSG1UVw>? MWrHTVUxRTBwMzFOwG0> MV6yNFg5PDJyOB?=
U937 M4D1bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnvCO|IhcA>? NFnnUpVFVVOR M33jfGdKPTB;MD6zPUDPxE1? MnHUNlA5QDR{MEi=
A431 NHrVZ3dEgXSxdH;4bYMhSXO|YYm= NGTqUGw4OiCq MUXDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDBOFMyKGOnbHzzJI93\XKneIDy[ZN{cW6pIFXHSnIhf2m2aDDJR|UxKG:oIESuNkDPxE1? M162O|IyODhyNkK5
A549 Mn7oR5l1d3SxeHnjJGF{e2G7 NVX6cpFLPzJiaB?= MonBR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVU1QSClZXzsd{BwfmW{ZYjwdoV{e2mwZzDISGFEKHerdHigTWM2OCCxZjCxMlgh|ryP Mo\UNlExQDB4Mkm=
CAL27 NVLXWHliS3m2b4TvfIlkKEG|c3H5 MYS3NkBp M{fjcGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGNCVDJ5IHPlcIx{KG:4ZYLlfJBz\XO|aX7nJGVITlJid3n0bEBKSzVyIH;mJFMvOiEQvF2= MoHyNlExQDB4Mkm=
HeLa NWnKTlVKS3m2b4TvfIlkKEG|c3H5 NVLC[3loPzJiaB?= NH3GZlREgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJ\UyjIHPlcIx{KG:4ZYLlfJBz\XO|aX7nJGhFSUNid3n0bEBKSzVyIH;mJFEvPSEQvF2= NH7vZ|kzOTB6ME[yPS=>
Sf21 Mnm4T4lv[XOnIFHzd4F6 M3O1RVMhcA>? Mn;QTY5pcWKrdHnvckBw\iCIbHHnJJRi\2enZDDoeY1idiC{ZXPvcYJqdmGwdDDISGFEQCCneIDy[ZN{\WRid3n0bEBKSzVyIH;mJFEvOiEQvF2= MX[yNVA5ODZ{OR?=
SKBR3 M3noemN6fG:2b4jpZ{BCe3OjeR?= NWG4TFMxPzJiaB?= MYfDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDTT2JTOyClZXzsd{BwfmW{ZYjwdoV{e2mwZzDISXIzKHerdHigTWM2OCCxZjCyMlYh|ryP MYSyNVA5ODZ{OR?=
SKOV3 MWTDfZRwfG:6aXOgRZN{[Xl? NIPGSZM4OiCq NEjWOoNEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBUU0:YMzDj[YxteyCxdnXy[ZhxemW|c3nu[{BJTVJ{IIfpeIghUUN3MDDv[kAzNjJizszN NFX2SmkzOTB6ME[yPS=>
COR-L23 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWLZWXRROTBizszN MnywO|IhcA>? MoLxSG1UVw>? M4HoPGdKPTB;MT6xJO69VQ>? M2T3c|IyODhyNkS3
DU145 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{LMR|ExKM7:TR?= MlOzO|IhcA>? MmnaSG1UVw>? MmfmS2k2OD1zLkC1JO69VQ>? NV;rNpJ4OjFyOEC2OFc>
LoVo MlX5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkLkNVAh|ryP MYC3NkBp M{LadGROW09? Ml;RS2k2OD1zLkeg{txO M1fQVFIyODhyNkS3
MCR5-SV2 NVzhXmhjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVPLOFlmOTBizszN NFrXRWQ4OiCq NVn0NI4zTE2VTx?= Mo\hS2k2OD1{LkGg{txO MVGyNVA5ODZ2Nx?=
HCT116 MXjLbY5ie2ViQYPzZZk> NU[5Nms6OzBizszN NYPNVYR1OzBiaB?= NYjOfnhGTE2VTx?= NUm2NVdZUW6qaXLpeIlwdiCxZjDISGFEPiCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4Yh[WyyaHGteJVjfWyrbjDhZ4V1gWyjdHnvci=> NVvHU|Z4OjFyOEC2OFc>
HCT116 NVHYNG91U2mwYYPlJGF{e2G7 MmnlN|Ah|ryP Mn:2N|AhcA>? NGj2dWJFVVOR NVP6[GhjUW6qaXLpeIlwdiCxZjDISGFEOSCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4YhcGm|dH;u[UBJO0t7IHHj[ZR6dGG2aX;u MoDINlExQDB4NEe=
U937 NFTSPW1McW6jc3WgRZN{[Xl? MYi1JO69VQ>? Mne4NlQhcA>? MYXEUXNQ MomyTY5pcWKrdHnvckBw\iCqaYP0c45mKGGlZYT5cJRz[W6|ZnXyZZNmKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIH;mJIFk\XS7bHH0bY9vKG:oIHjpd5RwdmViSEOgZZQhUzl? NGfn[VIzOTJ7MkS5Ni=>
U937 NFrxb|FMcW6jc3WgRZN{[Xl? M1XaXlUh|ryP MknZNlQhcA>? M3rGNGROW09? NYXGeIViUW6qaXLpeIlwdiCxZjDobZN1d26nIHHj[ZR6dHS{YX7z[oVz[XOnIHHzd4V{e2WmIHHzJIlv[3KnYYPlJI9nKGGlZYT5cIF1cW:wIH;mJIhqe3SxbnWgTFMh[XRiS{G4 MoPONlEzQTJ2OUK=
U937 M1L5PGtqdmG|ZTDBd5NigQ>? Ml7POUDPxE1? MmPCNlQhcA>? M{nObGROW09? NITrUoNKdmirYnn0bY9vKG:oIHjpd5RwdmViYXPleJltfHKjboPm[ZJie2ViYYPz[ZN{\WRiYYOgbY5kemWjc3Wgc4YheGGwLXHj[ZR6dGG2ZXSgbIl{fG:wZTDIOEBt\X[nbB?= M3nQVlIyOjl{NEmy
U937 MWLLbY5ie2ViQYPzZZk> MUW1JO69VQ>? NIjSR|UyPSCvaX6= NXTVVHVJTE2VTx?= Mk\5TY5pcWKrdHnvckBw\iCqaYP0c45mKGGlZYT5cJRz[W6|ZnXyZZNmKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIH;mJIhqe3SxbnWgTFMh[WOndInsZZRqd25ibHX2[Yw> NEn0VVgzOTJ7MkS5Ni=>
A2780 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEHy[II6PiCq MYTEUXNQ NIDXUpRKSzVyPUGuOlIh|ryP M3HEWlIyPjN2NEOw
COLO205 MnXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NE[1VoE6PiCq NWm4VHlXTE2VTx?= NXXMTHE6UUN3ME2yMlEzKM7:TR?= Ml7jNlE3OzR2M{C=
Hep3B M1vVTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXjLN|FxPDhiaB?= MYDEUXNQ NH2zdlhIUTVyPUGuNlEh|ryP NV\n[lF3OjF5MUKxOFY>
GM11272 MnTkSpVv[3Srb36gRZN{[Xl? NGnEUJcyODBibl2= M2\S[lczKGh? NYXNeZNFTE2VTx?= MmTjVoVi[3SrdnH0bY9vKG:oIF3lR5AzKG23dHHueEBmgHC{ZYPzbY9vKGG2IEGwJJRwKDFyMDDuUS=> M37LcVIyQDRyN{G2
CFBE41o M2Pke2tqdmG|ZTDBd5NigQ>? MV61JO69VQ>? M2jnd2ROW09? NHPrTXNFd3ewIILl[5Vt[XSrb36gc4YhUESDQ{egZZQhOC5{IITvJFUhfU1? MUSyNVk5PDl3OB?=
CFBE41o M3vm[GZ2dmO2aX;uJGF{e2G7 NYTtcYJGOSEQvF2= NE\GWYYzPCCq MWXEUXNQ M1zEc3Jme3SxcnH0bY9vKG:oIFPGWHIh\GWudHHGOVA5KG23dHHueEB1emGoZnnjb4lv\yC2bzDj[YxtKHO3cn\hZ4Uh[XNiZ3z5Z49nd3Kvcx?= MYeyNVk5PDl3OB?=
DU145 MnmzT4lv[XOnIFHzd4F6 MWKyMlUh|ryP M2f5elI1KGh? NED0NWRFVVOR NYnKS|d2UW6qaXLpeIlwdiCxZjDISGFEKGG|c3Xzd4VlKGG|IIXwdoVofWyjdHnvckBw\iCyMkH3ZYYyKHC{b4TlbY4h\XiycnXzd4lwdg>? MnG3NlIzPjBzNk[=
DU145 Ml3yT4lv[XOnIFHzd4F6 NXrFcnpFPSEQvF2= NES0W|czPCCq NUTiSmVKTE2VTx?= Mnr0TY5pcWKrdHnvckBw\iCKRFHDJIF{e2W|c3XkJIF{KGirc4TvcoUhUDRiYXPleJlt[XSrb36= MVSyNlI3ODF4Nh?=
DU145 Mn3uT4lv[XOnIFHzd4F6 NEmxWIQ2KM7:TR?= NVjIdWIzOjRiaB?= NGTscpNFVVOR MnrSTY5pcWKrdHnvckBw\iCKRFHDJIF{e2W|c3XkJIF{KGirc4TvcoUhUDNiaInw[ZJi[2W2eXzheIlwdg>? MYKyNlI3ODF4Nh?=
786-0 Mn\HS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF2xbWk3NjJizszN NWLhfGF1PzJiaB?= MmX5SG1UVw>? MUfHTVUxRTNwMjFOwG0> M2rveFIzPDN3Nk[5
A498 NX;ycWxoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NX;Fb|hpPi5{IN88US=> M4\MWlczKGh? NUXN[pNRTE2VTx?= Mn\4S2k2OD1zLk[g{txO MmDiNlI1OzV4Nkm=
A549/ATCC MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NW\GeJBwPi5{IN88US=> NEPPU4w4OiCq NYTsWG1LTE2VTx?= M4jjNmdKPTB;MT62JO69VQ>? MlLrNlI1OzV4Nkm=
ACHN MlPmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mkj3Ok4zKM7:TR?= MX63NkBp NITne5dFVVOR MkHGS2k2OD1zLkOg{txO NHjPXXozOjR|NU[2PS=>
BT549 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmPCOk4zKM7:TR?= NXy4O4hQPzJiaB?= NVPhV4o6TE2VTx?= NGW0eIhIUTVyPUGuN{DPxE1? MYeyNlQ{PTZ4OR?=
EKVX NIDFWY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWC2MlIh|ryP M1nTdlczKGh? MXrEUXNQ NHziboRIUTVyPUGuN{DPxE1? NGXuUIIzOjR|NU[2PS=>
HCT15 NWrlenhzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoPkOk4zKM7:TR?= NIXrWGs4OiCq MX;EUXNQ M2HYbGdKPTB;Mj61JO69VQ>? MmrpNlI1OzV4Nkm=
HOP92 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFvTU4o3NjJizszN NIXQPGc4OiCq M2TMcmROW09? MmThS2k2OD12IN88US=> MUKyNlQ{PTZ4OR?=
IGROV1 NV;rS4xoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWe2MlIh|ryP MY[3NkBp NGTGPWtFVVOR NVTqfmJtT0l3ME2xMlMh|ryP MUOyNlQ{PTZ4OR?=
LOXIMVI M4LoWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH70flM3NjJizszN M3H6SFczKGh? MXXEUXNQ NHf5cYxIUTVyPUGg{txO NGfFcXYzOjR|NU[2PS=>
M14 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHzXNJY3NjJizszN NFjDfFY4OiCq M{XRVWROW09? NX;Je|JqT0l3ME2xMlMh|ryP MUKyNlQ{PTZ4OR?=
MALME-3M M{TnTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH3neYE3NjJizszN M{njR|czKGh? NIXmTYhFVVOR NVLn[FJ5T0l3ME2wMlMzKM7:TR?= MoDuNlI1OzV4Nkm=
MCF10A MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV3BOZR4Pi5{IN88US=> MmL1OFghcA>? NEC4dYFFVVOR MVvHTVUxRTlwNjFOwG0> MU[yNlQ{PTZ4OR?=
MDA-MB-435 NXPRNm1vT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3\ESlYvOiEQvF2= M4\ORlczKGh? NETte4ZFVVOR MkLlS2k2OD1yLkWg{txO NEXiOWgzOjR|NU[2PS=>
MDA-MB-468 NYDWTZljT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4LLSVYvOiEQvF2= M3HiNFczKGh? M3zIbGROW09? NYXWdXV[T0l3ME2wMlY{KM7:TR?= NIm1S2szOjR|NU[2PS=>
MOLT4 MmD4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUC2MlIh|ryP M{W5RlczKGh? NEDofIdFVVOR NFm2WFJIUTVyPUCuOEDPxE1? MY[yNlQ{PTZ4OR?=
NCI-ADR-RES M2LKS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoLJOk4zKM7:TR?= MWS3NkBp MlTQSG1UVw>? NIT5THVIUTVyPUCuNVYh|ryP M1vrSVIzPDN3Nk[5
NCI-H23 M{G4Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{LRbVYvOiEQvF2= Mn\FO|IhcA>? NWXW[IdFTE2VTx?= NHvUSWZIUTVyPUGg{txO NXu4bGZGOjJ2M{W2Olk>
NCI-H322M M4DsR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2T5RVYvOiEQvF2= MYC3NkBp MW\EUXNQ MlPGS2k2OD1yLke5JO69VQ>? NEHuUIkzOjR|NU[2PS=>
NCI-H460 MlfuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWe2MlIh|ryP MY[3NkBp NILXcnFFVVOR MmHyS2k2OD1yLke5JO69VQ>? NVXuXWRpOjJ2M{W2Olk>
NCI-H522 NGnIcHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWK2MlIh|ryP MnvhO|IhcA>? MXLEUXNQ Mm[3S2k2OD1yLkWg{txO NXPN[GI3OjJ2M{W2Olk>
OVCAR3 Mo\iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MV62MlIh|ryP NWLvNZNzPzJiaB?= NWTSXYNYTE2VTx?= NUHSZVFuT0l3ME2xMlMh|ryP NYjUcZp3OjJ2M{W2Olk>
OVCAR4 Mn;jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXq0TnBDPi5{IN88US=> MnWxO|IhcA>? NXnUVXF7TE2VTx?= M{\WWGdKPTB;NDFOwG0> NYrxbJM3OjJ2M{W2Olk>
OVCAR5 NIfPbFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEjpNFU3NjJizszN M4Djc|czKGh? MoHVSG1UVw>? M4rUXGdKPTB;MD63PUDPxE1? NXLXZlFkOjJ2M{W2Olk>
OVCAR8 NWSxc4RjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFHodlc3NjJizszN M3jiU|czKGh? M4fDfWROW09? M{j3dmdKPTB;MD61JO69VQ>? NVW1U|NVOjJ2M{W2Olk>
RXF393 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnTjOk4zKM7:TR?= NFPXN|g4OiCq NFHONWlFVVOR M4jJeGdKPTB;MT6zJO69VQ>? MVOyNlQ{PTZ4OR?=
SF268 MlLWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4nSW|YvOiEQvF2= NYrWdpZZPzJiaB?= NYmzboVVTE2VTx?= NFPDXHFIUTVyPUGuOkDPxE1? NF61OWwzOjR|NU[2PS=>
SF295 Mn\ES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXO2MlIh|ryP NHHv[444OiCq NITtXZVFVVOR M{HkVWdKPTB;MT62JO69VQ>? NFf5[44zOjR|NU[2PS=>
SF539 M4\WNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnXuOk4zKM7:TR?= NGK3V4Y4OiCq MojtSG1UVw>? MX;HTVUxRTJizszN NEn1V2szOjR|NU[2PS=>
SK-MEL-2 NVnTeIVrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWjjWmxCPi5{IN88US=> Mo\vO|IhcA>? MmrJSG1UVw>? NGjVdFlIUTVyPUGuN{DPxE1? M2HT[lIzPDN3Nk[5
SK-MEL-28 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3KwblYvOiEQvF2= MUC3NkBp NG\POVBFVVOR NXjWWIRWT0l3ME2xJO69VQ>? MUCyNlQ{PTZ4OR?=
SK-MEL-5 M{Wwb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYPMVlZJPi5{IN88US=> NUXqZYd2PzJiaB?= Mn[ySG1UVw>? MVTHTVUxRTBwNkOg{txO Mo\DNlI1OzV4Nkm=
SKOV3 NWPGSVVUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGnmW2Y3NjJizszN MlfOO|IhcA>? MnS3SG1UVw>? NFrjTVdIUTVyPUGg{txO Mk\4NlI1OzV4Nkm=
SN12C NYjQVnZnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXi2MlIh|ryP NGXlelk4OiCq Mkm3SG1UVw>? MlLsS2k2OD1{IN88US=> MnjDNlI1OzV4Nkm=
SNB19 Ml3wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M32yOlYvOiEQvF2= M3;tS|czKGh? NWrPe41YTE2VTx?= MoTDS2k2OD1yLk[zJO69VQ>? MXWyNlQ{PTZ4OR?=
SNB75 NGnsbolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mm\hOk4zKM7:TR?= M{\ZZlczKGh? NVvodXQ4TE2VTx?= MYDHTVUxRTBwN{mg{txO MoHWNlI1OzV4Nkm=
SR NY\3SVBOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVnRZlVJPi5{IN88US=> NVfUcZVWPzJiaB?= MWPEUXNQ M2LaemdKPTB;MD60JO69VQ>? MVOyNlQ{PTZ4OR?=
T47D NIS3XHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWfP[ZlZPi5{IN88US=> M{jYZlczKGh? NUPF[Wx2TE2VTx?= NV7SS2tuT0l3ME2wMlUh|ryP MX:yNlQ{PTZ4OR?=
TK10 MmDaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX22MlIh|ryP M37lSVczKGh? NWPye|YxTE2VTx?= MX\HTVUxRTBwNkOg{txO MUWyNlQ{PTZ4OR?=
UACC257 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MofUOk4zKM7:TR?= MlSzO|IhcA>? MYnEUXNQ MX7HTVUxRTBwNTFOwG0> NH:0ZXkzOjR|NU[2PS=>
UACC62 M1[wT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHnvdGg3NjJizszN MnrlO|IhcA>? NWPYeHNiTE2VTx?= M{PGeGdKPTB;MD60JO69VQ>? NInUemszOjR|NU[2PS=>
UO31 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIHTN2Y3NjJizszN Mme3O|IhcA>? NHm0em5FVVOR MXvHTVUxRTBwNTFOwG0> NVnPeI1kOjJ2M{W2Olk>
Hep3B NXPnRoRXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmXKOFghcA>? NHr1RnhFVVOR MYPHTVUxRTBwNkmg{txO MUOyNlQ{QTh4Mx?=
BE(2)-C NHuxVJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1GzUVczKGh? MWXEUXNQ MlrGTWM4OD1{IN88US=> NEjKWmYzOjl|MkOxOi=>
Bel7402 NWXnbpBbT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHPk[4Q4OiCq NYrBbWV3TE2VTx?= MYPHTVkxRTF5IN88US=> NVHi[2ZjOjNyNkGzO|Y>
Bel7404 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH\VfJk4OiCq M2LLRmROW09? NXjjUWdQT0l7ME2xPEDPxE1? M4\YR|I{ODZzM{e2
BGC823 NFnveG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUXrVlVXPzJiaB?= NG\DS2VFVVOR NG\lfHRIUTlyPUeuOUDPxE1? M1zoPFI{ODZzM{e2
MGC803 MoTzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnjRO|IhcA>? M2jmbmROW09? NW\tfGFlT0l7ME2xNE45KM7:TR?= NFXB[okzOzB4MUO3Oi=>
SGC7901 MmnWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXy3NkBp M3qy[mROW09? MknpS2k6OD17LkSg{txO NHnNPGMzOzB4MUO3Oi=>
SKHEP1 M37lemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlfzO|IhcA>? MnH3SG1UVw>? NGnBcGdIUTlyPUG3JO69VQ>? NXT1NIxTOjNyNkGzO|Y>
SMMC7721 NFf6XXNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV7CZnNjPzJiaB?= MYPEUXNQ NXP0bmhmT0l7ME2yNEDPxE1? MUOyN|A3OTN5Nh?=
NUGC3 M4S0eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFLz[Y0yOCEQvF2= NHKwdYpIUT1{Lkm0JO69VQ>? M4jQ[FI{OTZ|M{Oy
A2780 CisR MUjLbY5ie2ViQYPzZZk> NIj1TmIyQCCq MlT5TY5pcWKrdHnvckBw\iCKRFHDJJdqfGhiSVO1NEBw\iByLkS0JO69VQ>? NVHse41JOjN{NUK2NFM>
CAL27 sens MWLLbY5ie2ViQYPzZZk> NGXkU40yQCCq MoDMTY5pcWKrdHnvckBw\iCKRFHDJJdqfGhiSVO1NEBw\iByLkO2JO69VQ>? MlrvNlMzPTJ4MEO=
CAL27 CisR NWjGOVZFU2mwYYPlJGF{e2G7 NGXDOXcyQCCq MXfJcohq[mm2aX;uJI9nKEiGQVOge4l1cCCLQ{WwJI9nKDBwNkGg{txO Mli1NlMzPTJ4MEO=
KYSE-510 CisR M13zbmtqdmG|ZTDBd5NigQ>? MWixPEBp NX\pS5ZDUW6qaXLpeIlwdiCxZjDISGFEKHerdHigTWM2OCCxZjCwMlU6KM7:TR?= NVP1NGp4OjN{NUK2NFM>
KYSE-510 sens MmmyT4lv[XOnIFHzd4F6 NWnIbW1oOThiaB?= M1r3V2lvcGmkaYTpc44hd2ZiSFTBR{B4cXSqIFnDOVAhd2ZiMD63JO69VQ>? NHL6eYEzOzJ3Mk[wNy=>
MDA-MB-231 sens NVrLVmplU2mwYYPlJGF{e2G7 NHvqSVcyQCCq MoTjTY5pcWKrdHnvckBw\iCKRFHDJJdqfGhiSVO1NEBw\iByLk[xJO69VQ>? NIPCVGozOzJ3Mk[wNy=>
MDA-MB-231 CisR NYL1VW9DU2mwYYPlJGF{e2G7 M4q2OFE5KGh? NGnEZWtKdmirYnn0bY9vKG:oIFjERWMhf2m2aDDJR|UxKG:oIECuOlEh|ryP M13he|I{OjV{NkCz
ES2 M4Hk[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoXVOFghcA>? MY\EUXNQ Mmj5TWM2OD1zMj63JO69VQ>? M2raU|I{PDl|NES5
MDA-MB-231 NILLcnFMcW6jc3WgRZN{[Xl? NY\5WmM2OTBizszN M{fKUFMxKG2rbh?= NVf1RW1RTE2VTx?= NHrnNJRKdmirYnn0bY9vKG:oIFjERWMz[Q>? MmnRNlM1QTN2NEm=
MDA-MB-231 Ml;kT4lv[XOnIFHzd4F6 NWXtb4ZOOSEQvF2= NFfncVUzPCCq NXz4TZBTTE2VTx?= M1fCT2lvcGmkaYTpc44hd2ZiSFTBR|Yh[XO|ZYPz[YQh[XNiYXPleJlt[XSrb36gcIV3\Wy|IH;mJJR2[nWuaX6= NVLiNHRrOjN2OUO0OFk>
HS68 NVvJRYpSS3m2b4TvfIlkKEG|c3H5 Ml21NVAh|ryP NXL4elV2PzJiaB?= MUPEUXNQ MXTJR|UxRTRwNjFOwG0> M{Cx[|I{PTdyNUSy
MEF M33ZNGN6fG:2b4jpZ{BCe3OjeR?= MkDKNVAh|ryP NG[0Zok4OiCq NETtPZhFVVOR NFXTUXdKSzVyPUSuOEDPxE1? MY[yN|U4ODV2Mh?=
BGC823 NXXkdHdyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1zIW2ROW09? MYfHTVUxRTNwMEmg{txO NI\zNVQzOzZyMUewOi=>
High5 MXXLbY5ie2ViQYPzZZk> NFnMb5AzPCCq MnPGTY5pcWKrdHnvckBw\iCqdX3hckBz\WOxbXLpcoFvfCCKRFHDOkB4cXSqIFnDOVAhd2ZiMD6wPUDPxE1? NGTvW2gzOzZyMkWyNy=>
High5 NGnHOZBMcW6jc3WgRZN{[Xl? MkjTNlQhcA>? NH65V4NKdmirYnn0bY9vKG:oIHj1cYFvKHKnY3;tZolv[W62IFjERWMyKHerdHigTWM2OCCxZjCwMlEzKM7:TR?= Ml;ENlM3ODJ3MkO=
High5 MVXLbY5ie2ViQYPzZZk> Ml7wNlQhcA>? NXTFXnZ2UW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDISGFEOyC5aYToJGlEPTBib3[gNE4yPyEQvF2= MoLBNlM3ODJ3MkO=
A549 NEfrb2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlH0SG1UVw>? M2XnW2lEPTB;MT6wO|kh|ryP MUWyN|Y1PDJzMB?=
HCT116 NWDhdZlPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NInMeGRFVVOR MlfmTWM2OD1yLke1O{DPxE1? M4HIZlI{PjR2MkGw
K562 NVX2cFR2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3XsV2ROW09? Mn7TTWM2OD1yLk[0OUDPxE1? NH;KR5kzOzZ2NEKxNC=>
GBC-SD M1jMPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4DTZ|Uh|ryP NV\1bmVEPzJiaB?= Ml;1SG1UVw>? MVvJR|UxRTF2Lkig{txO NGW2RpUzOzdyN{K2NC=>
HGC27 M4jubGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mmj3OUDPxE1? NFLqN|g4OiCq NHrUb5lFVVOR NXT1[nFLUUN3ME21MlQh|ryP M3TMTFI{PzB5Mk[w
HL60 MnXQT4lv[XOnIFHzd4F6 MXy1JO69VQ>? NUfNcmRnOjRiaB?= NWm4PY5ITE2VTx?= NIW0OndKdmirYnn0bY9vKG:oIFjERWM> NETk[IMzOzdyN{K2NC=>
Vero NVv1TWJiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF3zd484OiCq NFjNN5hFVVOR MnzCTWM2OD1yLkmg{txO NVzhcJpHOjN5OE[0OVI>
NCI60 MoT2R5l1d3SxeHnjJGF{e2G7 NX\3bXZGPDhiaB?= M4TGRWROW09? NGnE[|JIUT1yLkWzJO69VQ>? NWjOXlhROjRyMUWzNlc>
SW620 MoDxR5l1d3SxeHnjJGF{e2G7 NEL0eoQ1QCCq NUn6UFN3TE2VTx?= NETPSpZIUT1yLkW0JO69VQ>? NXTISYdNOjRyMUWzNlc>
U251 NF\yTGlEgXSxdH;4bYMhSXO|YYm= M{npelQ5KGh? MnfMSG1UVw>? M{Pa[WdKRTFwNUOg{txO NVfJcnZvOjRyMUWzNlc>
KM12 MWnDfZRwfG:6aXOgRZN{[Xl? M2n0R|Q5KGh? NYTVZVJbTE2VTx?= M2XlV2dKRTFwOEig{txO Mn;sNlQxOTV|Mke=
Hs578T MWTDfZRwfG:6aXOgRZN{[Xl? NGLkTmQ1QCCq M{\ObmROW09? M4X1V2dKRTRwOEOg{txO MU[yOFAyPTN{Nx?=
MDA-MB-231 M1\SXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoPSOFghcA>? M3fp[WlEPTB;MD6xOkDPxE1? NUThclJHOjRyOUWwNVY>
MCF7 NUfFNFVMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlXtOFghcA>? M17DZWdKRTBwNEWg{txO MXeyOFEyQTV3NR?=
MDA-MB-435 MmjMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUi0PEBp MkD0S2k:OC56ODFOwG0> NYK2epZDOjRzMUm1OVU>
AsPC1 Mk\BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWfFdJNHOzBizszN MkP0OFghcA>? MmqxSG1UVw>? MoO0TWM2OD1|Lk[2JO69VQ>? MWKyOFE5PTN5OB?=
Jurkat E6.1 MoH6T4lv[XOnIFHzd4F6 MoS4NkBp NUnSNYxkTE2VTx?= NIrhXYxKdmirYnn0bY9vKG:oIFjERWM1KHerdHigTWM2OCCxZjCwMlA1KM7:TR?= MVSyOFI3OTh4Mh?=
KG1 MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MY[0PEBp NYDuVFQxUUN3ME2xMlE2KM7:TR?= NGLrOIYzPDV{NUCwNy=>
HEL MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHnob4w1QCCq NHXmZXZFVVOR M4nOXmlEPTB;MD60PUDPxE1? Ml[zNlQ3QTRyNUW=
HSC3 Mk[wR5l1d3SxeHnjJGF{e2G7 NH:2bokyOiCq NHrNVFJFVVOR NVLvXFB2UUN3ME2wMlcyKM7:TR?= M{GySlI1PzZ4NU[w
HT-29 NHzzZ3BEgXSxdH;4bYMhSXO|YYm= NEHVXpkyOiCq Mk\NSG1UVw>? NV[4[4ZrUUN3ME2wMlczKM7:TR?= NX;D[4l4OjR5Nk[1OlA>
KB M{LjXmN6fG:2b4jpZ{BCe3OjeR?= NWDmcnJ6OTJiaB?= MV7EUXNQ M3[yU2lEPTB;MD63OUDPxE1? MVKyOFc3PjV4MB?=
H460 MlPFR5l1d3SxeHnjJGF{e2G7 M2XqcVEzKGh? NGXibVZFVVOR M2nDXGlEPTB;MD64NkDPxE1? M{jXNVI1PzZ4NU[w
MONE1 M2fvdmN6fG:2b4jpZ{BCe3OjeR?= M1THTlEzKGh? NYm1R2M6TE2VTx?= MYfJR|UxRTFwMUig{txO NXewVYdyOjR5Nk[1OlA>
MKN45 NHnD[G5EgXSxdH;4bYMhSXO|YYm= NEnGcowyOiCq MWDEUXNQ NX7TSGp1UUN3ME2xMlI2KM7:TR?= M4fS[FI1PzZ4NU[w
TSGH NFz5TGxEgXSxdH;4bYMhSXO|YYm= NVm2RlR[OTJiaB?= M1;TN2ROW09? NYrjTWhLUUN3ME2yMlA6KM7:TR?= NEXJfJEzPDd4NkW2NC=>
HL60 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4T0NFczKGh? MVXEUXNQ Mo\VS2k2OD1yLkmzJO69VQ>? M3LnfVI1QTByNUCw
HEK293 M3jJUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4riXlczKGh? MnPzSG1UVw>? NIDhWWFIUTVyPUGzJO69VQ>? MlvpNlQ6ODB3MEC=
Jurkat MYTDfZRwfG:6aXOgRZN{[Xl? MYGxNFAh|ryP Mo\CO|IhcA>? M3XVTmdKPTB;MD65JO69VQ>? NILVOHEzPDlyMEe0Ny=>
GM15850 M2[xUmtqdmG|ZTDBd5NigQ>? NXPiems{Oi53IN88US=> NVnGdYNmQTZiaB?= MlPZSG1UVw>? NVPuVlNu\G:nczDuc5QhcW6qaXLpeEBJTEGFIHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGirc4TvcoUhUDNibInzbY5mKDF2IHHj[ZR6dGG2aX;uJI9nKE[[TjDn[Y5m MlvMNVY6OjF|Nke=
GM15850 NVKzPIhRU2mwYYPlJGF{e2G7 MXOyMlUh|ryP NVHHSVkzQTZiaB?= M1LuO2ROW09? NWXFeGpr\G:nczDuc5QhcW6qaXLpeEBJTEGFIHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGirc4TvcoUhUDRibInzbY5mKDViYXPleJlt[XSrb36gc4YhTliQIHflcoU> NYDUXpZ1OTZ7MkGzOlc>
GM15850 NYTGVYRmU2mwYYPlJGF{e2G7 Mlj5Nk42KM7:TR?= MnSzPVYhcA>? Mlr5SG1UVw>? MmnV[I9meyCwb4SgbY5pcWKrdDDISGFEKGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFQhdHm|aX7lJFEzKGGlZYT5cIF1cW:wIH;mJGZZViCpZX7l NYTyZVF[OTZ7MkGzOlc>
GM15850 NHzJZmpMcW6jc3WgRZN{[Xl? NFnmZoMzNjVizszN NEO0WFU6PiCq NHrETldFVVOR NYnTN5ZT\G:nczDuc5QhcW6qaXLpeEBJTEGFIHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGirc4TvcoUhUDNibInzbY5mKDliYXPleJlt[XSrb36gc4YhTliQIHflcoU> MnzONVY6OjF|Nke=
GM15850 NFTIWlRMcW6jc3WgRZN{[Xl? MWCyMlUh|ryP M{XhVlk3KGh? MUTEUXNQ NWTOfYxX\G:nczDuc5QhcW6qaXLpeEBJTEGFIHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGirc4TvcoUhUDRibInzbY5mKDhiYXPleJlt[XSrb36gc4YhTliQIHflcoU> MVuxOlkzOTN4Nx?=
GM15850 M4XtUGtqdmG|ZTDBd5NigQ>? NVi3bpFOOi53IN88US=> NGHmXlM6PiCq NXnv[ZNqTE2VTx?= MYTkc4V{KG6xdDDpcohq[mm2IFjERWMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gbIl{fG:wZTDIOEBtgXOrbnWgNVYh[WOndInsZZRqd25ib3[gSnhPKGenbnW= M37wc|E3QTJzM{[3
GM15850 NF7jN5ZHfW6ldHnvckBCe3OjeR?= NWrCbG9uPSEQvF2= NVnEPIxIOTJiaB?= MWLEUXNQ M1\IT4hieyCwbzDl[oZm[3Rib36gSnhPKG2UTlGg[ZhxemW|c3nvci=> Mmi1NVY6OjF|Nke=
U937 MVvLbY5ie2ViQYPzZZk> NWS5U|JzPSEQvF2= M1rWblI1KGh? MXTEUXNQ MXHoZZMhdm9iZX\m[YN1KG:wIHHsdIhiKHS3YoXsbY4h[WOndInsZZRqd25? NUOyWFV6OTd2NEe3OVA>
U937 NFLubIdMcW6jc3WgRZN{[Xl? MV6xJO69VQ>? NXjZO4FPOjRiaB?= MmrBSG1UVw>? MoHobIF{KG6xIHXm[oVkfCCxbjDhcJBp[SC2dXL1cIlvKGGlZYT5cIF1cW:w NULUSmxCOTd2NEe3OVA>
PANC1 MlXCSpVv[3Srb36gRZN{[Xl? M2X5dlEh|ryP NVizOI9DOjRiaB?= NEPvdYNld2W|IH7veEBqdmO{ZXHz[UBqdiCyMkfrbZAyKGenbnWg[ZhxemW|c3nvci=> NX\JNoNSOTd3OEi3OFQ>
PANC1 NH7xbXpHfW6ldHnvckBCe3OjeR?= M1LrOFEh|ryP Mn3QOFghKGh? MoDa[I9meyCwb4SgbY5kemWjc3WgbY4heDJ5a3nwNUBo\W6nIHX4dJJme3Orb36= NVLsVFZuOTd3OEi3OFQ>
Caco-2 NH:1fYtHfW6ldHnvckBCe3OjeR?= NE\5b4g2KM7:TR?= MkS0NlQhcA>? MYLEUXNQ MlW3[I9meyCwb4SgbY5lfWOnIGCyNXdCTjFiZ3Xu[UBmgHC{ZYPzbY9v MV2yNFE1Ozh2MB?=
SCC4 MknmSpVv[3Srb36gRZN{[Xl? NHntOJAyKM7:TR?= MYixNEBucW5? M37WWmROW09? NHfwV5pp[XNibn:gZYdwdmm|dDDhZ5Rqfmm2eTDheEBXTFJiYYPz[ZN{\WRiYYOgbY5lfWO2aX;uJI9nKEO\UEK0JIdmdmViZYjwdoV{e2mxbh?= MmrONlA1PTJ{MkW=
A549 M3nZU2Z2dmO2aX;uJGF{e2G7 NH7XdZI2KM7:TR?= M3XtWFMhcA>? M4Px[WROW09? M17zcoRw\XNibn;0JIlv\HWlZTDheZRweGijZ4mgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iTFOzTWk> Mn:zNlA5PTV{MEi=
HCT116 Mk[5T4lv[XOnIFHzd4F6 NUT0SGVLOC5|IN88US=> MWmzNEBp NHu4VZNFVVOR Mk\2[I9meyCwb4SgbY5pcWKrdDDISGFEOSCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4YhcGm|dH;u[UBJO0t7IHHj[ZR6dGG2aX;u MVmyNVA5ODZ2Nx?=
HepG2 MmftSpVv[3Srb36gRZN{[Xl? MYKxNEDPxE1? MmTWNlQhcA>? MojISG1UVw>? MX;kc4V{KG6xdDDpcoR2[2ViYYDvdJRwe2m|IHHzd4V{e2WmIHHzJIh6eGW{YXPleJlt[XSrb36gc4YheDV| NFu2eowzOTV2OEW4Ni=>
GM11272 NH6yToNHfW6ldHnvckBCe3OjeR?= NEO0N2gxNjFizszN M4LMbFczKGh? M4rqS2ROW09? M3LpNIRw\XNibn;0JJJm[WO2aY\heIUhVWWFcEKgcZV1[W62IHX4dJJme3Orb36= M3vSeFIyQDRyN{G2
MDA-MB-231 MUXLbY5ie2ViQYPzZZk> NES5c5cyOCEQvF2= MmHQOUBucW5? MUnEUXNQ M2Cyc4Rw\XNibn;0JIlvcGmkaYSgTGRCSzKj NH24NFgzOzR7M{S0PS=>
MDA-MB-231 NFjIeXpMcW6jc3WgRZN{[Xl? MmPaNUDPxE1? NITNWHYzPCCq NH\pRYVFVVOR NIXE[GRld2W|IH7veEBqdmirYnn0JGhFSUN4IHHzd4V{e2WmIHHzJIFk\XS7bHH0bY9vKGyndnXsd{Bw\iC2dXL1cIlv MkLyNlM1QTN2NEm=
K562 MUfLbY5ie2ViQYPzZZk> M4PnbYRw\XNibn;0JIlvcGmkaYSgTGRCSw>? MUCyN|U6OTFzMR?=
Jurkat M{jKTWN6fG:2b4jpZ{BCe3OjeR?= NUjCO3hZOjBizszN NWqwXVJbPzJiaB?= NHTLNVFFVVOR MVvuc{BkgXSxdH;4bYNqfHliYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36= NIfCUHczPDNyNEO0PC=>
HCT116 NETi[ZBCeG:ydH;zbZMhSXO|YYm= Mk\LN{DPxE1? MYqyOEBp NXzlXY1zTE2VTx?= MX3kc4V{KG6xdDDpcoR2[2ViYYDvdJRwe2m|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKHB3MzDwdo91\WmwIHzleoVt NFLXUW0zPDd4NkW2NC=>
KASUMI-1 NH3TdXhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHX1TGJKSzVyPUm5MlE4KG6P MWnTRW5ITVJ?
KARPAS-45 Mn75S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoPHTWM2OD1zN{OuPFkhdk1? Ml\QV2FPT0WU
BHT-101 M{\EUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4jQVWlEPTB;MkS0MlE5KG6P NXPyRox{W0GQR1XS
H9 MlLvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXvJR|UxRTJ3NT6wOEBvVQ>? NXjhO4V[W0GQR1XS
PA-1 NHPud5ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1;o[2lEPTB;Mki2MlI3KG6P M4KyUnNCVkeHUh?=
NEC8 M3Lp[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFvsWnVKSzVyPUK4PU4{QCCwTR?= MknqV2FPT0WU
MHH-PREB-1 NEjKOlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml\xTWM2OD1{OUSuOVMhdk1? M1rU[XNCVkeHUh?=
NB7 MmDyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYPJR|UxRTN2NT63OEBvVQ>? NXftXJd4W0GQR1XS
A3-KAW NX;PXHQ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHOzUmxKSzVyPUSwNE42QSCwTR?= NWXQfWZpW0GQR1XS
NB69 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MorxTWM2OD12MUGuO|Ehdk1? Mn;uV2FPT0WU
EoL-1-cell M1\0fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUTJR|UxRTR3NEK1JI5O MlryV2FPT0WU
CHP-212 M{DhOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NW\yWI1WUUN3ME20OVcvPTNibl2= NHnDcHdUSU6JRWK=
C2BBe1 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVjJR|UxRTR5Mj6xPUBvVQ>? NVjjbJlHW0GQR1XS
697 MlvpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX\JR|UxRTR5Mz60NUBvVQ>? NXHLdItHW0GQR1XS
BCPAP NXH5ZVNVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnzITWM2OD13MEGuOFIhdk1? MnnBV2FPT0WU
L-363 NIfuSJVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEjidGtKSzVyPUWwN{4yKG6P M4LROnNCVkeHUh?=
ES8 MlHDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2rk[GlEPTB;NUKzMlU{KG6P MonaV2FPT0WU
BE-13 NWfVUpVXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{WxVGlEPTB;NUK2Mlk3KG6P MWXTRW5ITVJ?
CTB-1 MoqxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3nDcGlEPTB;NUO3MlkzKG6P NHzSeXhUSU6JRWK=
HD-MY-Z M32xd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NVz6fot5UUN3ME21N|gvOTNibl2= NYex[WtnW0GQR1XS
NKM-1 M{HNdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX;qWXdYUUN3ME21OFQvOjdibl2= NEHW[nlUSU6JRWK=
NCI-H720 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn21TWM2OD13NkCuNVghdk1? NHzUW2lUSU6JRWK=
KY821 NFPMV|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NEGxS4RKSzVyPUW2N{4zPSCwTR?= M2q3OXNCVkeHUh?=
OVCAR-5 NXLLVHpYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWLJR|UxRTV5Nj6xNUBvVQ>? NFzqRVZUSU6JRWK=
CTV-1 MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX23OIN{UUN3ME21PFEvPTZibl2= NWLmSJYxW0GQR1XS
P12-ICHIKAWA M4jhfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mo\HTWM2OD13OU[uOVEhdk1? MoTlV2FPT0WU
DB MmHFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWXKUIJYUUN3ME21PVgvPTdibl2= MUnTRW5ITVJ?
CHL-1 NGTTVIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mnq2TWM2OD14NEKuNFghdk1? MmXTV2FPT0WU
A4-Fuk MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVXaN41KUUN3ME22OFQvQTFibl2= NHrrR5hUSU6JRWK=
MV-4-11 M4C5eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn;RTWM2OD14NUmuNUBvVQ>? MVnTRW5ITVJ?
RPMI-8226 NVG2eZFWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUnJR|UxRTZ5OD6xPEBvVQ>? MVLTRW5ITVJ?
NB14 M4CzWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGS0UmFKSzVyPU[5Ok46PSCwTR?= NF:1em9USU6JRWK=
DOHH-2 NVjJS4RUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3fzUmlEPTB;N{C2MlY5KG6P NEL2cYdUSU6JRWK=
D-423MG NHfRS2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn:xTWM2OD15ME[uPFkhdk1? M4XFc3NCVkeHUh?=
D-283MED NWjDWXJJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnjYTWM2OD15MUSuNVQhdk1? M{LaRXNCVkeHUh?=
ES1 MmDIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVrJR|UxRTd{ND60JI5O MX;TRW5ITVJ?
GOTO M37ocWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGe1fItKSzVyPUeyPU4yOiCwTR?= Mk\nV2FPT0WU
NCI-H209 Ml:4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGr3bmZKSzVyPUeyPU46KG6P NWn2SVl4W0GQR1XS
MOLT-13 M4TXVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1G4XWlEPTB;N{O4Mlk5KG6P M3X4WHNCVkeHUh?=
ATN-1 NHL4OZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYHJR|UxRTd2MD6yPEBvVQ>? NIKwOpdUSU6JRWK=
DU-4475 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUXJR|UxRTd3MT65NUBvVQ>? NUDIWpZnW0GQR1XS
NB10 MnKzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH7SNJNKSzVyPUe1NU46OiCwTR?= Ml\pV2FPT0WU
KG-1 MoDrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mo\YTWM2OD15N{WuOFUhdk1? Ml\1V2FPT0WU
MOLT-4 M{O4Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGTYU4ZKSzVyPUe4O{41PiCwTR?= Mor4V2FPT0WU
TE-1 MnLNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVrJR|UxRTd7MT6xJI5O NYfTe4tQW0GQR1XS
SBC-1 M2nTfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml3TTWM2OD15OUOuPFQhdk1? M{jTTXNCVkeHUh?=
HEL NYjhZXNuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mn3qTWM2OD16ME[uNFghdk1? MlHSV2FPT0WU
SK-MEL-2 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1;z[mlEPTB;OEC5MlQ1KG6P NFXGbmtUSU6JRWK=
KU812 M3y0UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3HocGlEPTB;OEGzMlEhdk1? M1fqPHNCVkeHUh?=
RPMI-8866 MkSzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnP2TWM2OD16MUOuOlchdk1? NYDJVm1sW0GQR1XS
ALL-PO MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYHJR|UxRThzND62OkBvVQ>? MoD0V2FPT0WU
LU-139 MojtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2\TTGlEPTB;OEKyMlg3KG6P MoPEV2FPT0WU
RS4-11 MlXzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmK1TWM2OD16M{KuOFUhdk1? MnPqV2FPT0WU
EW-18 MnPaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlG1TWM2OD16M{KuPVYhdk1? Mof2V2FPT0WU
P30-OHK MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NI\hfVlKSzVyPUizOU44KG6P MYrTRW5ITVJ?
D-566MG MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFH2NXFKSzVyPUizPE43OiCwTR?= MYnTRW5ITVJ?
HSC-4 M4LUV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHXCZ4hKSzVyPUi0Ok42OSCwTR?= NIPQO41USU6JRWK=
QIMR-WIL MoTQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWi1T25yUUN3ME24OlIvODNibl2= NFzsTJdUSU6JRWK=
SW954 NUX3eVJqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{TQS2lEPTB;OE[zMlE3KG6P NXjSXmtkW0GQR1XS
HGC-27 NWfTNpB7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYPJR|UxRTh5Mj6zOEBvVQ>? M2fGN3NCVkeHUh?=
HH MofXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{e5OmlEPTB;OEm0MlEzKG6P NGfnNIRUSU6JRWK=
KE-37 Mlq3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NX7BR5FLUUN3ME24PVQvPjJibl2= M4DOXnNCVkeHUh?=
SK-N-DZ MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHe3fXBKSzVyPUmwNE41OyCwTR?= MVPTRW5ITVJ?
J-RT3-T3-5 MlWwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1jWVGlEPTB;OUGwMlQ6KG6P NGXyNlZUSU6JRWK=
A427 NVnnO4M4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXXJdnF{UUN3ME25NlAvQDRibl2= MkHtV2FPT0WU
ECC10 NUL5XGJ5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVHrbHhyUUN3ME25OFUvQDdibl2= NVTDd2ZoW0GQR1XS
EW-1 NVn1eph5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFr5WJRKSzVyPUm0O{4zPiCwTR?= MUPTRW5ITVJ?
MIA-PaCa-2 M{\xOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoHsTWM2OD17NEmuNVIhdk1? NFLiXFBUSU6JRWK=
HCC2218 NIj5T2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2XTOWlEPTB;OUW4MlQ5KG6P NYfIOlFoW0GQR1XS
HAL-01 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVX0S4VvUUN3ME25OlgvODRibl2= NYfrcmV3W0GQR1XS
RD NUP4bJU4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnnTTWM2OD17N{SuOFUhdk1? NWXYTWRMW0GQR1XS
SK-N-AS NVzPNHZkT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1n4WGlEPTB;OUi4MlEhdk1? NFPtfndUSU6JRWK=
ML-2 Ml;1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUHJR|UxRTFwMEC0NFch|ryP NYjNRYxQW0GQR1XS
MEL-HO M4nLWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn3rTWM2OD1zLkCwOVgzKM7:TR?= MlnkV2FPT0WU
MS-1 NGP2TmZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVnJR|UxRTFwMEC2NVch|ryP NIDKcldUSU6JRWK=
NCI-SNU-1 M2rlbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NH3HeXhKSzVyPUGuNFI{OzFizszN M3HKVXNCVkeHUh?=
8505C MoH2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUnJR|UxRTFwMEKzN|Eh|ryP NILkWYVUSU6JRWK=
MN-60 MmPQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlHhTWM2OD1zLkCyOlgh|ryP NYjoco5UW0GQR1XS
SAS MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYC0R4R5UUN3ME2xMlA1ODhzIN88US=> NU[0UppzW0GQR1XS
EFM-19 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVvJR|UxRTFwMES4O|kh|ryP MUPTRW5ITVJ?
Ca9-22 NV7BW5JiT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3HobmlEPTB;MT6wOVExPyEQvF2= NXv6Woo5W0GQR1XS
NBsusSR NHO1PJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkTLTWM2OD1zLkC1NVY3KM7:TR?= NH:2e2pUSU6JRWK=
NB13 NUjBWWVvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYHnW5NoUUN3ME2xMlA2PTBzIN88US=> MUHTRW5ITVJ?
SF295 NWXXU3p{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWXDe4tSUUN3ME2xMlA3PjJ2IN88US=> Mm\OV2FPT0WU
U-2-OS NIXI[21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mo\qTWM2OD1zLkC3PVEyKM7:TR?= NYjKcWROW0GQR1XS
NCI-H526 NH:zPXJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn7hTWM2OD1zLkC4NlkyKM7:TR?= NYnUT3pHW0GQR1XS
KMOE-2 M{\JZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoPrTWM2OD1zLkC5OFIzKM7:TR?= MoWwV2FPT0WU
RCM-1 NUPr[m54T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHzCfXJKSzVyPUGuNVIyODJizszN MkXZV2FPT0WU
MC116 NIXZOVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkjFTWM2OD1zLkGzOlIyKM7:TR?= M4fIWnNCVkeHUh?=
NCI-H1092 NIH1[XNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGHrXHZKSzVyPUGuNVU1ODZizszN NXzRdXg4W0GQR1XS
EW-3 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnfMTWM2OD1zLkG3NlEzKM7:TR?= M2\wfHNCVkeHUh?=
HCT-116 M4HUPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWXHNFJiUUN3ME2xMlE4PzVizszN MV;TRW5ITVJ?
MC-IXC MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4\2NmlEPTB;MT6xO|g5OSEQvF2= MljSV2FPT0WU
LB1047-RCC NEPXSmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1vzT2lEPTB;MT6xPFMyOiEQvF2= MoHMV2FPT0WU
VM-CUB-1 M{DVdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFTMTolKSzVyPUGuNVkyODhizszN MonvV2FPT0WU
NB5 M13DR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX\JR|UxRTFwMUm4OVYh|ryP MYPTRW5ITVJ?
SKG-IIIa M2Tsfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHHpSoRKSzVyPUGuNlM1PjRizszN M2\C[nNCVkeHUh?=
HO-1-N-1 NIftU5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{Ox[WlEPTB;MT6yN|g{PSEQvF2= M4LrfHNCVkeHUh?=
EFO-27 M1rSbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYPheY8xUUN3ME2xMlI2ODR|IN88US=> NVnDbXN3W0GQR1XS
MHH-NB-11 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVvJR|UxRTFwMkizNlkh|ryP NELJOmlUSU6JRWK=
SW620 NUm1dXQ3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUSzOoRQUUN3ME2xMlI6ODF6IN88US=> MUnTRW5ITVJ?
MOLT-16 NIHlRVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mk\TTWM2OD1zLkK5O|k4KM7:TR?= MX\TRW5ITVJ?
NTERA-S-cl-D1 NETXe2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV;ZXHRsUUN3ME2xMlMyPzZzIN88US=> MYfTRW5ITVJ?
VA-ES-BJ MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3n2SGlEPTB;MT6zNlQ4PyEQvF2= MXfTRW5ITVJ?
HCC1419 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mmr0TWM2OD1zLkO0NFI4KM7:TR?= M3\xbHNCVkeHUh?=
NCI-H69 NGjKenVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NITOeZZKSzVyPUGuN|QyOTJizszN MYrTRW5ITVJ?
DEL MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWHJR|UxRTFwM{WxOlIh|ryP NXyyNGVoW0GQR1XS
LXF-289 NXKyNY9CT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1vFXGlEPTB;MT6zOVI1KM7:TR?= M3XWfHNCVkeHUh?=
EW-11 NETlRWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mlv6TWM2OD1zLkO2NFI3KM7:TR?= MVzTRW5ITVJ?
KP-4 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mlr6TWM2OD1zLkO3NFg2KM7:TR?= NF7UVnFUSU6JRWK=
NOS-1 MoPRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH73bJFKSzVyPUGuOFEyQTRizszN MnLCV2FPT0WU
SK-NEP-1 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{TXcWlEPTB;MT60NVY6OyEQvF2= M{njXXNCVkeHUh?=
LAMA-84 MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYLWdpRiUUN3ME2xMlQ{QTR3IN88US=> NVzHSnJLW0GQR1XS
ES5 NULFTIhnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3vDeWlEPTB;MT60OFMh|ryP MW\TRW5ITVJ?
HuO9 NUi1ZWtIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWjYUIZ3UUN3ME2xMlQ2OzZ{IN88US=> M2m3UnNCVkeHUh?=
COLO-684 MljTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NITNTVVKSzVyPUGuOFYyOThizszN M1PXTnNCVkeHUh?=
EW-24 NWLVfXpqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MUXJR|UxRTFwNE[1N|Eh|ryP M2qzTHNCVkeHUh?=
BV-173 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXvVVHR1UUN3ME2xMlQ4OjlzIN88US=> MmXYV2FPT0WU
NCI-H1770 NVTuNGhXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MV7JR|UxRTFwNEi1N|Yh|ryP NXLlOYlYW0GQR1XS
HuP-T4 NYLFWnNGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3W2bGlEPTB;MT60PVMh|ryP NYHEfZJ4W0GQR1XS
TYK-nu MoHRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MofkTWM2OD1zLkS5PFUyKM7:TR?= MXTTRW5ITVJ?
YH-13 NWfNeoZrT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml60TWM2OD1zLkS5PFk1KM7:TR?= NH63eHJUSU6JRWK=
H4 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIO4N4VKSzVyPUGuOVA6OTJizszN M3TpNXNCVkeHUh?=
OVCAR-8 MlPGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX7JR|UxRTFwNUS0O|ch|ryP M4OzWXNCVkeHUh?=
NCI-H23 MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVfJNJBNUUN3ME2xMlU1PjR3IN88US=> MX3TRW5ITVJ?
ES7 M4PNXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX\3PHRPUUN3ME2xMlU1Pzd|IN88US=> NHv4N2VUSU6JRWK=
COR-L88 M1XTO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUfTWXRUUUN3ME2xMlU3PDJ2IN88US=> MnvFV2FPT0WU
TI-73 NFX3PHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmfFTWM2OD1zLkW5NFYh|ryP MX7TRW5ITVJ?
RT-112 NYXZZYtWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NE\ONXVKSzVyPUGuOVkzQDRizszN NXjNNmVzW0GQR1XS
HuO-3N1 NHXpd2ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHXMcZRKSzVyPUGuOVk{QDVizszN Mn\SV2FPT0WU
HC-1 M4j5fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUjJR|UxRTFwNUm4OlYh|ryP NX3rV|h7W0GQR1XS
HT55 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3vCdmlEPTB;MT62OVE{OSEQvF2= MmLSV2FPT0WU
IA-LM MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{PlU2lEPTB;MT62PVI4QCEQvF2= NILSRWdUSU6JRWK=
EM-2 MnnjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2fmSmlEPTB;MT63NFAyPCEQvF2= Mm\DV2FPT0WU
MHH-ES-1 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M173XmlEPTB;MT63NFQ{PSEQvF2= Ml\xV2FPT0WU
CAL-27 NXXvSFJvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2HMfmlEPTB;MT63NFYzOSEQvF2= MVTTRW5ITVJ?
COLO-800 M3n4fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoTuTWM2OD1zLkexNVc6KM7:TR?= NITqfYxUSU6JRWK=
HCE-T MmHtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1nheWlEPTB;MT63NVUh|ryP M4DqUHNCVkeHUh?=
CAMA-1 NFfSZ3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHG4[mtKSzVyPUGuO|E6PzFizszN NG[4PHVUSU6JRWK=
LOXIMVI MmexS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{TsfWlEPTB;MT63NlEyKM7:TR?= NYfIcW5EW0GQR1XS
NH-12 M3P0d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmD6TWM2OD1zLkeyOlkyKM7:TR?= NV\tcXo{W0GQR1XS
TCCSUP MkDBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEHKWZFKSzVyPUGuO|I5OjlizszN M1vTRXNCVkeHUh?=
MDA-MB-361 MkPRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXrJR|UxRTFwN{OxOVch|ryP MkW3V2FPT0WU
EW-16 M{LvUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX2xO49LUUN3ME2xMlc1OTB5IN88US=> NULhSW15W0GQR1XS
SNU-423 NVnRe5V3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlLNTWM2OD1zLke1PFI4KM7:TR?= Mo\lV2FPT0WU
Daoy NGnVWGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2nGcmlEPTB;MT63OlMyQSEQvF2= MVHTRW5ITVJ?
ES4 Mn6wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1q1XGlEPTB;MT63PFc1OSEQvF2= MWHTRW5ITVJ?
PFSK-1 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVXJR|UxRTFwOECzO{DPxE1? M1;6dHNCVkeHUh?=
ES3 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{fjfGlEPTB;MT64NlY5OSEQvF2= NYG1[41bW0GQR1XS
ONS-76 MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWrvUWppUUN3ME2xMlgzQDl5IN88US=> MYrTRW5ITVJ?
JVM-3 NFXGS3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NETpWXBKSzVyPUGuPFU1PTFizszN MmnUV2FPT0WU
OS-RC-2 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUfJR|UxRTFwOEexOVEh|ryP MV\TRW5ITVJ?
COLO-320-HSR M3vCTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXPnUFcyUUN3ME2xMlg5OTl5IN88US=> MljCV2FPT0WU
HN Mn;OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUO4[5FOUUN3ME2xMlg5PzJ3IN88US=> NULBVJVSW0GQR1XS
HT NYDpeY9iT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NF7lZ4FKSzVyPUGuPFg6PDdizszN NEDI[HZUSU6JRWK=
LoVo MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnXITWM2OD1zLki5PFEh|ryP NF;lbmFUSU6JRWK=
CGTH-W-1 NUjLXJB4T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXXJR|UxRTFwOEm5OFYh|ryP MV7TRW5ITVJ?
NB6 M4TFR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml3wTWM2OD1zLkmxNlk5KM7:TR?= NVPJNldUW0GQR1XS
EW-22 M2jCfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWLJR|UxRTFwOUK4PFch|ryP M3vRbnNCVkeHUh?=
ES6 M3zGcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{fJNWlEPTB;MT65N|Y{OSEQvF2= MmTUV2FPT0WU
SCC-15 M4C5NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MorZTWM2OD1zLkmzPFE6KM7:TR?= M4Pad3NCVkeHUh?=
HL-60 NYntVlN5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{m2XGlEPTB;MT65N|kxOiEQvF2= M3H2OnNCVkeHUh?=
human HOP-92 NETFS21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWjkWFBEUUN3ME2xMlk1ODZ3IN88US=> MXjTRW5ITVJ?
SW626 NHHObGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF\vNYJKSzVyPUGuPVQ5QTlizszN M1O4WXNCVkeHUh?=
HEC-1 M3j6OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M3P2TGlEPTB;MT65OVM3KM7:TR?= NGjMdo1USU6JRWK=
LB2241-RCC M{C3S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NU[xXHRYUUN3ME2xMlk5OjNzIN88US=> NELO[o5USU6JRWK=
Ramos-2G6-4C10 MorGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVPJR|UxRTFwOUm0PVMh|ryP MV\TRW5ITVJ?
A101D NFX6bGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYTJR|UxRTJwMkCzNFMh|ryP MU\TRW5ITVJ?
NCI-H446 NHT2Z4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3ftb2lEPTB;Mj6wOFU6QSEQvF2= MkjJV2FPT0WU
SBC-5 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHfxdWdKSzVyPUKuNFYyPDdizszN NFzvd|BUSU6JRWK=
HOS MnrVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1[3[2lEPTB;Mj6wO|Y2OyEQvF2= M{m5fHNCVkeHUh?=
K5 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYfoOZFMUUN3ME2yMlA4QDFzIN88US=> NFrIUJZUSU6JRWK=
HLE MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkPjTWM2OD1{LkC4OVI6KM7:TR?= NYjOXGVVW0GQR1XS
HSC-2 MmTCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXjpOXlqUUN3ME2yMlEzQDl6IN88US=> M4PxfnNCVkeHUh?=
LCLC-97TM1 M2LDWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWXrR4FvUUN3ME2yMlE1PTh|IN88US=> MYDTRW5ITVJ?
DMS-273 NUHpS4VST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWnGN4V5UUN3ME2yMlE1QDN5IN88US=> MY\TRW5ITVJ?
TE-8 NVXwU|VmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{Cz[2lEPTB;Mj6xOVc3PSEQvF2= MoTvV2FPT0WU
DSH1 MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlTNTWM2OD1{LkG2N|k5KM7:TR?= MVzTRW5ITVJ?
CAL-51 NXj1SnNnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXn3d5JsUUN3ME2yMlE3Pjl7IN88US=> NH7pR21USU6JRWK=
IST-SL1 NGHqSlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NULTV3JvUUN3ME2yMlE3QDR2IN88US=> NUS2fVdjW0GQR1XS
GCT Mn\jS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUXJR|UxRTJwMUe3O{DPxE1? NY[2e5l4W0GQR1XS
SW948 NYLIR29HT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MnTXTWM2OD1{LkG4OFU3KM7:TR?= M{XQWXNCVkeHUh?=
NOMO-1 M4Ox[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M12weGlEPTB;Mj6xPVMyPyEQvF2= M3nyWXNCVkeHUh?=
C8166 NV7DSWN2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGfGdFNKSzVyPUKuNlE{OzRizszN MmL3V2FPT0WU
OC-314 MoH0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFW1WIVKSzVyPUKuNlMzPTlizszN NVzsSWpNW0GQR1XS
CAL-39 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFvoOW5KSzVyPUKuNlM3OjZizszN MnLmV2FPT0WU
MDA-MB-453 NHfsfmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV3JR|UxRTJwMkSyO|Uh|ryP NXGycphjW0GQR1XS
A673 NUjUd2pmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWS3NZpEUUN3ME2yMlI2QDZ{IN88US=> NIXRS|JUSU6JRWK=
HTC-C3 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3H6PWlEPTB;Mj6yOlg2KM7:TR?= NVLDT406W0GQR1XS
NCI-H1666 NEfCc2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{fTbWlEPTB;Mj6yPFEyOSEQvF2= M1vq[HNCVkeHUh?=
PSN1 MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml;oTWM2OD1{LkK4PVE{KM7:TR?= M2SyRnNCVkeHUh?=
GI-1 NHzMXpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIXGcVlKSzVyPUKuN|A2PDNizszN MlzBV2FPT0WU
HuH-7 NFnWdJlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVvJR|UxRTJwM{C2N|ch|ryP NVPOTXBvW0GQR1XS
JAR NIKwfmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mk[2TWM2OD1{LkOxPVg4KM7:TR?= NF:yfY5USU6JRWK=
5637 M1PvZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NILvWXNKSzVyPUKuN|IyOjlizszN MmniV2FPT0WU
GB-1 MlPSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWTBSHRDUUN3ME2yMlMzOzN3IN88US=> NIjUdGVUSU6JRWK=
KP-N-YS M3fIVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGH6cIlKSzVyPUKuN|I3OTVizszN MlTDV2FPT0WU
OAW-42 M4q4S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWXJR|UxRTJwM{O0NVYh|ryP M2mzXnNCVkeHUh?=
8-MG-BA NUHMVJBjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXnUTVd2UUN3ME2yMlM{QTB4IN88US=> M3v2UnNCVkeHUh?=
RH-18 MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MlfoTWM2OD1{LkO1NFIzKM7:TR?= MVfTRW5ITVJ?
NCI-H1155 M1S5R2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIOxdYRKSzVyPUKuN|Y4OjVizszN NU\lSYZOW0GQR1XS
NB17 NIj4ZlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M33ITGlEPTB;Mj6zPFI1OyEQvF2= M2nVU3NCVkeHUh?=
NCI-H1437 M1fpSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFTPV|ZKSzVyPUKuOFE5PzNizszN MU\TRW5ITVJ?
SN12C NEToOIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV3JR|UxRTJwNEOyNVQh|ryP MoKzV2FPT0WU
HSC-3 MknYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoK2TWM2OD1{LkS0OVA6KM7:TR?= MonLV2FPT0WU
GAMG MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MUPJR|UxRTJwNES1OlEh|ryP NH;FOWhUSU6JRWK=
HT-1080 NHfpPXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1rnO2lEPTB;Mj60OFg3PCEQvF2= Mn3tV2FPT0WU
A549 NFvFSnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYHJR|UxRTJwNES4PVMh|ryP M1\0e3NCVkeHUh?=
KNS-62 M33QbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUfJR|UxRTJwNEWwOlEh|ryP NYD6TnJVW0GQR1XS
YKG-1 MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHfMbIhKSzVyPUKuOFU1OzdizszN M1znd3NCVkeHUh?=
LU-134-A NWPpc4oyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWT1TWo6UUN3ME2yMlQ4ODB6IN88US=> MoLUV2FPT0WU
FADU M1:3PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIW5[Y9KSzVyPUKuOFcyPjJizszN M2P2SnNCVkeHUh?=
TGBC11TKB NGDpTIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXnx[3BqUUN3ME2yMlQ4OTd5IN88US=> NHvhO3JUSU6JRWK=
HT-3 NGPEbZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV\JR|UxRTJwNEm1N|Uh|ryP MmHoV2FPT0WU
NCI-H2170 NHPJVHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnXRTWM2OD1{LkWwOVQ6KM7:TR?= NWrnfJNYW0GQR1XS
Mo-T M37hRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYrJR|UxRTJwNUC5Nlch|ryP MmnnV2FPT0WU
CCRF-CEM NIHWO5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYHJR|UxRTJwNUOwOFMh|ryP NXzWWJFFW0GQR1XS
KU-19-19 Mnq4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUL2RZRoUUN3ME2yMlU{PTF|IN88US=> MlPmV2FPT0WU
NCI-H1048 NHfmOXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYG2S4VKUUN3ME2yMlU2ODJ3IN88US=> MlzHV2FPT0WU
KOSC-2 NHnyPFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWfPWG93UUN3ME2yMlU3ODd4IN88US=> NIjvZVhUSU6JRWK=
A431 M3fqZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M{PwfGlEPTB;Mj61OlM{PSEQvF2= M{O0T3NCVkeHUh?=
COR-L23 MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3\Z[WlEPTB;Mj61PFU3PiEQvF2= MnXDV2FPT0WU
MKN28 M3m2d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYC4[4lUUUN3ME2yMlU6ODN5IN88US=> MnmzV2FPT0WU
22RV1 MlXhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUf4eo5rUUN3ME2yMlU6Ojd2IN88US=> MlPFV2FPT0WU
ABC-1 NXrXTZFTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MW\JR|UxRTJwNkC0OkDPxE1? NGTjSHZUSU6JRWK=
NCI-H2126 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{[zVGlEPTB;Mj62NFk5PCEQvF2= NFz2WpNUSU6JRWK=
DoTc2-4510 M1HGXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYXJR|UxRTJwNkKxPFUh|ryP NVW2V2dPW0GQR1XS
SCC-4 MkPlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWfJR|UxRTJwNkOwNVIh|ryP M4Xzb3NCVkeHUh?=
NCI-H661 NVHBSVFsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1\iS2lEPTB;Mj62OFA5PSEQvF2= MVPTRW5ITVJ?
RPMI-2650 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoLYTWM2OD1{Lk[0NVQ{KM7:TR?= M17GS3NCVkeHUh?=
NCI-H510A M1fTRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1XScGlEPTB;Mj62OFQzPiEQvF2= Ml\JV2FPT0WU
BPH-1 MoHES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkDVTWM2OD1{Lk[1PFUh|ryP MkHVV2FPT0WU
M14 NYHYbllvT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NULa[IlwUUN3ME2yMlY3QTl|IN88US=> MXvTRW5ITVJ?
G-402 NYnyeYJET3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYPDfIt4UUN3ME2yMlcxPDVzIN88US=> Mn3JV2FPT0WU
AsPC-1 MnjGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{Xob2lEPTB;Mj63NVE4KM7:TR?= M2LHeXNCVkeHUh?=
NB12 M4PP[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Ml63TWM2OD1{LkexO|Eh|ryP M1rFfHNCVkeHUh?=
SK-HEP-1 MmTTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4nrO2lEPTB;Mj63OFM6OSEQvF2= M33IPHNCVkeHUh?=
U-266 MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{TUfWlEPTB;Mj63O|EzOSEQvF2= M2L3ZnNCVkeHUh?=
AM-38 NXXCOmFwT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1jE[2lEPTB;Mj63O|M2PSEQvF2= MXLTRW5ITVJ?
PC-14 Mly5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWrzU5JVUUN3ME2yMlgxPTFizszN NF;1[ppUSU6JRWK=
EGI-1 MlTIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH6wenJKSzVyPUKuPFE4PDNizszN MWPTRW5ITVJ?
LS-411N MlPRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlfNTWM2OD1{LkiyN|Mh|ryP NYLFeXZwW0GQR1XS
BFTC-905 NWGwZmZ{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHOydGdKSzVyPUKuPFU2OjNizszN NIK1RVNUSU6JRWK=
CaR-1 MlS4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MknsTWM2OD1{Lki2JO69VQ>? NWjWTJVpW0GQR1XS
NCI-H292 M4PLUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGGxSJBKSzVyPUKuPFY2QTZizszN MYXTRW5ITVJ?
8305C NVfjPYU2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3TPXWlEPTB;Mj64OlY1PSEQvF2= NVrIWZk5W0GQR1XS
SNU-449 M1rRbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnvQTWM2OD1{Lki5NVgzKM7:TR?= MnfGV2FPT0WU
LCLC-103H MljDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXXoSFlMUUN3ME2yMlkxPDN6IN88US=> MWHTRW5ITVJ?
SW1573 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MofYTWM2OD1{Lkm2NFgzKM7:TR?= Ml\EV2FPT0WU
MLMA NUW0ZZg2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIThZ2hKSzVyPUKuPVY4OTdizszN NFXpW5VUSU6JRWK=
NCI-H1355 NX7sXWRCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVrJR|UxRTNwMEC3PVYh|ryP MVjTRW5ITVJ?
RMG-I NH;YVnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWOwRVJXUUN3ME2zMlAzPTl{IN88US=> MUnTRW5ITVJ?
BB65-RCC Mo\lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{jY[mlEPTB;Mz6wN|MyPCEQvF2= NEXGN3VUSU6JRWK=
PC-3 MmP5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUnJR|UxRTNwMEO4O|Qh|ryP MXzTRW5ITVJ?
SF268 NYHHXokxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M2LocmlEPTB;Mz6wOFUzOyEQvF2= MmHZV2FPT0WU
NCI-H810 Mk\IS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MojXTWM2OD1|LkC0PFI{KM7:TR?= NYHIcotFW0GQR1XS
MEG-01 NUTPfYo3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoT0TWM2OD1|LkC2NVY1KM7:TR?= MlXBV2FPT0WU
SW13 NVXVb2RQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{XvdmlEPTB;Mz6wO|g1PyEQvF2= NEDQT3pUSU6JRWK=
RH-1 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYHJR|UxRTNwMUCyO|gh|ryP NHzwUIdUSU6JRWK=
GT3TKB NHLuWVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NHvLbGtKSzVyPUOuNVEzQDNizszN NHv1NZRUSU6JRWK=
TK10 Mm\KS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmrZTWM2OD1|LkGzO|I1KM7:TR?= MVrTRW5ITVJ?
T-24 NIrPblJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYPJR|UxRTNwMUWwO{DPxE1? M{fuRXNCVkeHUh?=
A498 NHjOfodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVvJR|UxRTNwMkC4O|Eh|ryP M2LMRXNCVkeHUh?=
GR-ST MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFPEd3lKSzVyPUOuNlIyOzlizszN MXHTRW5ITVJ?
LB2518-MEL MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWPJR|UxRTNwMkKzPVgh|ryP MnPzV2FPT0WU
T47D NITB[GpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1zGUmlEPTB;Mz6yN|YzPyEQvF2= Mki5V2FPT0WU
NCI-H1651 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEHFbYdKSzVyPUOuNlQ3PDRizszN NWW3XY1FW0GQR1XS
EC-GI-10 NFLtXFBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXrJR|UxRTNwMk[xOVMh|ryP NF\JSHJUSU6JRWK=
HT-29 MmTaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NETR[oFKSzVyPUOuNlY3OTRizszN M1PHNnNCVkeHUh?=
GI-ME-N MmrZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWnJR|UxRTNwMkm1NVEh|ryP M2nTS3NCVkeHUh?=
SW756 NEThN4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MW\JR|UxRTNwMkm2Nlkh|ryP MlvEV2FPT0WU
RKO NXLtS3ZTT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NInlbI5KSzVyPUOuN|A4PTdizszN NIDNcnlUSU6JRWK=
NCI-H1563 Mm\yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3K2b2lEPTB;Mz6zN|AyQCEQvF2= MVvTRW5ITVJ?
DJM-1 M2ezXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoryTWM2OD1|LkO3Olc1KM7:TR?= M124dnNCVkeHUh?=
L-428 NWW1SpFKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{nuZ2lEPTB;Mz60NFA1PSEQvF2= MYjTRW5ITVJ?
NCI-H2122 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NFixPZNKSzVyPUOuOFE{OTJizszN NUXPSHNXW0GQR1XS
Ca-Ski MnH2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUPJR|UxRTNwNEW0N{DPxE1? NHLQeXpUSU6JRWK=
639-V NGC0VGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX\JR|UxRTNwNE[wOVch|ryP NVz2WGk6W0GQR1XS
SW1116 MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWHJR|UxRTNwNE[yOlkh|ryP MWLTRW5ITVJ?
DMS-114 M2\jXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NUn6dWNIUUN3ME2zMlQ4ODZ4IN88US=> MWLTRW5ITVJ?
MZ2-MEL Mln3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVnJR|UxRTNwNEe2PFEh|ryP NE\qN3hUSU6JRWK=
COLO-829 NXLLNot[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mk\jTWM2OD1|LkWwNFc{KM7:TR?= NGLhXI9USU6JRWK=
J82 M1[0[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGPC[oRKSzVyPUOuOVA2PyEQvF2= NVixTJVxW0GQR1XS
EW-13 NEDjcFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXP2cFBkUUN3ME2zMlUzPTFizszN MkL0V2FPT0WU
RXF393 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHTscllKSzVyPUOuOVMzQTRizszN M{jlUXNCVkeHUh?=
CAL-62 NEHDe2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYfsb3ZVUUN3ME2zMlU1PTF2IN88US=> NWH3XmxSW0GQR1XS
OCUB-M MlvZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MmrYTWM2OD1|LkW0OlY2KM7:TR?= NV3MVGlDW0GQR1XS
BT-474 NILRZWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{DKbWlEPTB;Mz62N|MyKM7:TR?= NHHvO2dUSU6JRWK=
KYSE-180 NFG2WpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{jTVGlEPTB;Mz62N|M4OiEQvF2= MW\TRW5ITVJ?
NCI-H650 MnTiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3K2UWlEPTB;Mz62OFI5PyEQvF2= NWHrWWFYW0GQR1XS
Detroit562 NHH0RmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF;XPYRKSzVyPUOuOlUxOjJizszN MUTTRW5ITVJ?
SW48 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHHN[3NKSzVyPUOuOlU3PTdizszN MWjTRW5ITVJ?
KYSE-450 MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVzGUYZtUUN3ME2zMlY5PTh{IN88US=> MnLSV2FPT0WU
KYSE-510 NWLHfohuT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWTJR|UxRTNwN{KxPFEh|ryP Mn73V2FPT0WU
GP5d MoLnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mo\MTWM2OD1|LkeyPVUh|ryP M1XkTnNCVkeHUh?=
RPMI-7951 MoL3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWj2cmJOUUN3ME2zMlc1PzJ|IN88US=> MnTzV2FPT0WU
Becker MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYTJR|UxRTNwN{WwNVIh|ryP MYjTRW5ITVJ?
WM-115 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2CyRWlEPTB;Mz63PFE6PSEQvF2= M373[HNCVkeHUh?=
G-401 NHLENnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MofZTWM2OD1|Lke5NFg2KM7:TR?= NHyzSolUSU6JRWK=
PANC-08-13 M1S2V2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFTtRZlKSzVyPUOuO|k3ODJizszN Mo\4V2FPT0WU
SW982 Mo\HS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGj0dJNKSzVyPUOuPFA2PTFizszN NUfJW3h7W0GQR1XS
D-263MG M3LzRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWTqPI1OUUN3ME2zMlgzODVzIN88US=> NH7IbI9USU6JRWK=
KM-H2 MkfOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYK1cm1vUUN3ME2zMlgzPjJ2IN88US=> MkfrV2FPT0WU
SK-MEL-3 MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3;qZ2lEPTB;Mz64Nlg1OSEQvF2= MYTTRW5ITVJ?
NCI-H1581 MkHkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MX\JR|UxRTNwOES0PFgh|ryP NUGyTWRvW0GQR1XS
LS-123 MoPyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH:wTGdKSzVyPUOuPFc6ODlizszN Ml;EV2FPT0WU
CAKI-1 NGP2O5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2PnRWlEPTB;Mz64PVA2OiEQvF2= NUXXU3FWW0GQR1XS
MEL-JUSO MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MY\JR|UxRTNwOEmxOVMh|ryP MXfTRW5ITVJ?
HCE-4 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEn4emtKSzVyPUOuPVE3PjNizszN Mm\vV2FPT0WU
TE-10 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVvJR|UxRTNwOUKwNUDPxE1? NUfufJRSW0GQR1XS
OVCAR-4 M2\ofmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MmD5TWM2OD1|LkmyPFg6KM7:TR?= Ml:zV2FPT0WU
ETK-1 MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX7FZ3MyUUN3ME2zMlk1PjN3IN88US=> NU\Xc2doW0GQR1XS
A2780 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1O0VGlEPTB;ND6wOVk3PiEQvF2= MmLpV2FPT0WU
LU-65 M2rBOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NGrkclNKSzVyPUSuNFc3OzNizszN MmfOV2FPT0WU
BHY NYjBT3lJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlLYTWM2OD12LkGyOFk2KM7:TR?= MYjTRW5ITVJ?
COR-L105 MnzsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVjJR|UxRTRwMUOwOVEh|ryP Moe2V2FPT0WU
CAL-12T MmfGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUHJR|UxRTRwMUOxNFMh|ryP NGTJV5JUSU6JRWK=
SCH M3XFSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoHxTWM2OD12LkG1O|Q{KM7:TR?= MWTTRW5ITVJ?
CW-2 M{Dn[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MX\JR|UxRTRwMUmwNFEh|ryP MVvTRW5ITVJ?
HCC1806 M{PPV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHLFSXJKSzVyPUSuNlA{OTJizszN MlrSV2FPT0WU
KP-N-YN NGPT[IxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVPmWYRLUUN3ME20MlIxQTJ5IN88US=> NFLDUIFUSU6JRWK=
T98G NHqydJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVHJR|UxRTRwMkKxOVch|ryP MXLTRW5ITVJ?
CAL-54 NVTWVnh5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEiwNG9KSzVyPUSuNlI{QDFizszN M2X0PHNCVkeHUh?=
CAL-33 NULBVoZ5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mkj3TWM2OD12LkKzNFY1KM7:TR?= M3;6RnNCVkeHUh?=
SNU-C2B NGjJd3pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NWP6NFNFUUN3ME20MlI1PzZ7IN88US=> NHjQe2VUSU6JRWK=
NUGC-3 M4DQ[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVTJR|UxRTRwMkW1NFUh|ryP MoPDV2FPT0WU
DOK MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmfpTWM2OD12LkK2OVk{KM7:TR?= MmnmV2FPT0WU
MMAC-SF NWjHeJA6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEjsclBKSzVyPUSuNlY5PTlizszN M4nvNHNCVkeHUh?=
KYSE-70 NHGxdmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnjCTWM2OD12LkK5N|Qh|ryP MYXTRW5ITVJ?
A204 MmfQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWfJR|UxRTRwM{W4NFMh|ryP MknyV2FPT0WU
SCC-25 M4jsfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NIr4OWVKSzVyPUSuN|U5OTlizszN MYXTRW5ITVJ?
EPLC-272H Mn\4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkXHTWM2OD12LkO4PVUh|ryP M4rPd3NCVkeHUh?=
CAL-120 NFLWcVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4fzRmlEPTB;ND6zPFk6OiEQvF2= MlnIV2FPT0WU
LS-513 Ml3RS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHrISWVKSzVyPUSuOFIyQThizszN MYnTRW5ITVJ?
CAPAN-1 NWP0WGhST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEHHR|lKSzVyPUSuOFI{QDJizszN MlTvV2FPT0WU
ESS-1 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NHnDbG5KSzVyPUSuOFI4OjRizszN MX3TRW5ITVJ?
GMS-10 NWjsV4g1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVTEbJRuUUN3ME20MlQzQDF7IN88US=> M33scXNCVkeHUh?=
NCI-N87 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYDDc5AxUUN3ME20MlUxQDZ6IN88US=> MVvTRW5ITVJ?
HMV-II NHj2Z2hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYLJR|UxRTRwNUG3N{DPxE1? MYXTRW5ITVJ?
COLO-741 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoPRTWM2OD12LkW1PVk1KM7:TR?= M3n4W3NCVkeHUh?=
MKN45 MmTrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{LYN2lEPTB;ND61O|c{OiEQvF2= NFHocGRUSU6JRWK=
OAW-28 M1\OU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1K4fGlEPTB;ND61PFM6QCEQvF2= M2riXHNCVkeHUh?=
OCI-AML2 NUGwNllXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIK0RWpKSzVyPUSuOlUzOzhizszN MUjTRW5ITVJ?
MDA-MB-231 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWDJR|UxRTRwN{CyOFMh|ryP NIftU|FUSU6JRWK=
NCI-H1648 NXmzNYc1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NILKXY1KSzVyPUSuO|IzPzNizszN NYLNbVBZW0GQR1XS
NCI-H1792 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYDJR|UxRTRwN{[xNFch|ryP NGTkdJFUSU6JRWK=
GCIY NGq4fFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUXJR|UxRTRwN{e0NlQh|ryP NWHOOG9VW0GQR1XS
Hs-578-T MlGxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NIrSXG1KSzVyPUSuO|c3PTVizszN M1rGNXNCVkeHUh?=
SW962 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGD6fWlKSzVyPUSuO|gxOTFizszN NVu0WYRMW0GQR1XS
NCI-H630 NIHSfHhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnzkTWM2OD12Lke4NFgyKM7:TR?= M2rD[3NCVkeHUh?=
786-0 NFvrWVlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NITOXnhKSzVyPUSuO|g4PzNizszN NGT0UIRUSU6JRWK=
FTC-133 NH3FemxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH;kWHJKSzVyPUSuO|kzPjNizszN MmD2V2FPT0WU
BT-20 NFjLVWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXXJR|UxRTRwN{m0Nlkh|ryP MYTTRW5ITVJ?
Mewo MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoXNTWM2OD12LkixO|Q4KM7:TR?= MU\TRW5ITVJ?
SW780 NYKyfJV1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4TQZmlEPTB;ND64OVc3PiEQvF2= NG\pWINUSU6JRWK=
OE33 MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MknjTWM2OD12Lki3O|E{KM7:TR?= MVXTRW5ITVJ?
HCC1569 Mn\IS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MU\JR|UxRTRwOEi0OVgh|ryP NHjxN|RUSU6JRWK=
TE-6 NVvrXlNIT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4DvOGlEPTB;ND65N|k4PyEQvF2= M4GxSXNCVkeHUh?=
SK-N-FI MmfzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWToZoZEUUN3ME20Mlk1PDJzIN88US=> M3[yOXNCVkeHUh?=
PANC-03-27 NWH5S4N6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYfJR|UxRTRwOUm5OlIh|ryP MkLsV2FPT0WU
MCF7 MnzGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWHJR|UxRTVwMEC3N|gh|ryP NVHJepdJW0GQR1XS
UACC-257 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXLM[JhrUUN3ME21MlAzQDR3IN88US=> NWHhO5FEW0GQR1XS
SW1088 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4\KemlEPTB;NT6wNlk1PCEQvF2= M{m0NHNCVkeHUh?=
A704 NF7VOIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnTHTWM2OD13LkCzNFYh|ryP MXvTRW5ITVJ?
A2058 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3K1T2lEPTB;NT6wOVkxQCEQvF2= NILJV4FUSU6JRWK=
Calu-3 NFjBfoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXnJR|UxRTVwME[0OVIh|ryP MlPvV2FPT0WU
RERF-LC-MS NIPhRW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NW\QZXdvUUN3ME21MlA3QTB|IN88US=> NIjoWmdUSU6JRWK=
AU565 M3npTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWjJR|UxRTVwMEm3NFIh|ryP NYjiNoJzW0GQR1XS
DMS-79 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4TubGlEPTB;NT6xN|g5OyEQvF2= M2nH[XNCVkeHUh?=
DK-MG MlPGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFrBRZFKSzVyPUWuNVg1OzhizszN M2DVUHNCVkeHUh?=
HuCCT1 NF\adGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3fJcGlEPTB;NT6yN|g2PiEQvF2= NG\XRo5USU6JRWK=
HT-144 NGPSeWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUfJR|UxRTVwMkS5PFch|ryP MkW1V2FPT0WU
M059J MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIfHTZZKSzVyPUWuNlU4PiEQvF2= MWTTRW5ITVJ?
COLO-792 NHK3PGtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M17rPWlEPTB;NT6yOlM2PiEQvF2= Mm[wV2FPT0WU
SF539 NIPye2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYTJR|UxRTVwMk[2N|Ih|ryP NIq5VZlUSU6JRWK=
SK-UT-1 MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M2n5cWlEPTB;NT6yO|c2OSEQvF2= MUfTRW5ITVJ?
NCI-H1703 NF6xd4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmruTWM2OD13LkO1PFI3KM7:TR?= M1jUNHNCVkeHUh?=
SW837 MnXSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEj6bnhKSzVyPUWuN|c5PzhizszN Mn7pV2FPT0WU
U251 NYfHTJBlT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3fhdWlEPTB;NT6zPVA6PiEQvF2= NWGzOGN2W0GQR1XS
SW1710 MkPDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NW\MUG9PUUN3ME21MlQyPTV2IN88US=> Mn7DV2FPT0WU
NCI-H1299 NUPXO3JJT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIXieZpKSzVyPUWuOFY{OzVizszN NHXuWZZUSU6JRWK=
RVH-421 M2P0Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV6wXoZoUUN3ME21MlQ6QTB6IN88US=> MXfTRW5ITVJ?
UM-UC-3 NEL4dXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NV7aXXVtUUN3ME21MlYzPjVzIN88US=> MYjTRW5ITVJ?
MDA-MB-175-VII M3HkWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWrkUoJkUUN3ME21MlY1ODRzIN88US=> NIXxWpdUSU6JRWK=
KYSE-270 MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVfTdohJUUN3ME21MlY3ODNzIN88US=> NFzrPJZUSU6JRWK=
COLO-668 MoPSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{HJNWlEPTB;NT63NVMzKM7:TR?= MXzTRW5ITVJ?
LN-405 NHvq[o5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3fXbWlEPTB;NT63N|A5PSEQvF2= MlTLV2FPT0WU
HT-1376 NVrjco14T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVrXbZQ6UUN3ME21Mlc5ODV{IN88US=> NHXXNZNUSU6JRWK=
769-P NVvFZWhWT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mmq0TWM2OD13Lki2O|E5KM7:TR?= MnfkV2FPT0WU
HuP-T3 M1HYcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4\t[GlEPTB;NT64PFY4PyEQvF2= MlTQV2FPT0WU
MDA-MB-415 NVT5c3JPT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmXUTWM2OD13LkmyNVM6KM7:TR?= MkTlV2FPT0WU
MKN7 NW[3VI94T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWPJR|UxRTVwOUi4JO69VQ>? M{jod3NCVkeHUh?=
KS-1 MnPUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoHNTWM2OD13Lkm4PFM3KM7:TR?= M4PCfnNCVkeHUh?=
647-V NE\Hb4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX7JR|UxRTVwOUmxOFgh|ryP MVTTRW5ITVJ?
COLO-679 MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Ml3NTWM2OD14LkCwNlU2KM7:TR?= MkXkV2FPT0WU
AN3-CA Mn3NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVXZdVBFUUN3ME22MlA{PDRzIN88US=> M4r0UHNCVkeHUh?=
C32 MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NX3WXGI6UUN3ME22MlE{ODN2IN88US=> MkKwV2FPT0WU
KM12 NHnCflVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX7JR|UxRTZwMkSwPVkh|ryP MojNV2FPT0WU
KINGS-1 MoDwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYryVXlIUUN3ME22MlI3OTV{IN88US=> NFHze|BUSU6JRWK=
KYSE-410 M3fNdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXHJR|UxRTZwM{C2OFUh|ryP MnG1V2FPT0WU
HPAF-II MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mny1TWM2OD14LkO1OFgh|ryP M3[wbnNCVkeHUh?=
LAN-6 Ml;LS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NH\4b4ZKSzVyPU[uOFk3OzFizszN MlGwV2FPT0WU
LU-99A NGLVNlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NUPFU2lmUUN3ME22MlU2QTh7IN88US=> M2\MfHNCVkeHUh?=
SJSA-1 NXzyW3Y5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWHJR|UxRTZwNU[zOFch|ryP NYXaeVcxW0GQR1XS
MSTO-211H M3u4PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn3lTWM2OD14LkeyNlM{KM7:TR?= NFOxVI1USU6JRWK=
SW900 M3vQOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEW2VGhKSzVyPU[uO|YzOjFizszN M2jCdXNCVkeHUh?=
LNCaP-Clone-FGC MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVLifllKUUN3ME22MlgxPDB|IN88US=> NIHGb4lUSU6JRWK=
OMC-1 NXfSWIVyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHP6[phKSzVyPU[uPFU1ODJizszN MWfTRW5ITVJ?
IST-MEL1 M3zxSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHnNSJlKSzVyPU[uPFk3PjlizszN NELsXGlUSU6JRWK=
TE-9 NXHHfHpsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHvBOm5KSzVyPU[uPFk5PDdizszN MmrwV2FPT0WU
NCI-H2030 M1jmdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEPZSlBKSzVyPU[uPVEzOjZizszN Ml\rV2FPT0WU
BFTC-909 NUjLeJB7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M{\GfWlEPTB;Nz6wNFY1OSEQvF2= NHy3PVhUSU6JRWK=
NCI-SNU-5 NUKwR2lzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFjZWlJKSzVyPUeuNFIyPTlizszN MlfPV2FPT0WU
TE-5 M{DjSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MY\JR|UxRTdwMEK4PFEh|ryP M4nZc3NCVkeHUh?=
SK-MES-1 NX32[mpMT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYHJR|UxRTdwMEW0Nlch|ryP NX;qXo1YW0GQR1XS
SHP-77 M3\tO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M17NS2lEPTB;Nz6xN|k2OiEQvF2= NVzaXoZRW0GQR1XS
NCI-H1623 NFji[oJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MnTzTWM2OD15LkG0NFczKM7:TR?= NXHKVYZVW0GQR1XS
TE-11 M2DIb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFTw[nRKSzVyPUeuNVUyQDRizszN NHfRPFVUSU6JRWK=
EKVX NXvWWZFnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXTJR|UxRTdwMUmyOlch|ryP NGjpPHRUSU6JRWK=
OVCAR-3 MmLWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVmxcoZEUUN3ME23MlIyOTN|IN88US=> NHnXZXlUSU6JRWK=
C3A NHTEUm9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX3JR|UxRTdwM{S1NkDPxE1? NETkV3NUSU6JRWK=
CFPAC-1 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWjybpNbUUN3ME23MlM3OjJ{IN88US=> M4T0dXNCVkeHUh?=
MG-63 M2PnNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlnLTWM2OD15LkSxPFQ6KM7:TR?= NXy2PZd4W0GQR1XS
KYSE-140 NWO4VlJzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXm2XGZiUUN3ME23MlQ1ODZzIN88US=> M4K3TXNCVkeHUh?=
MPP-89 M1nweGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXjNbok{UUN3ME23MlU6PzJ7IN88US=> MVvTRW5ITVJ?
COLO-824 MnPmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4q0d2lEPTB;Nz63Nlg3OyEQvF2= MVPTRW5ITVJ?
SiHa NUCxUnNyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGnUelhKSzVyPUeuPFM4ODdizszN NX2xdHM1W0GQR1XS
SNU-387 MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NEXSXlRKSzVyPUeuPFU{PDdizszN NHHqR25USU6JRWK=
A172 NHrBd4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlnnTWM2OD15Lki2NVczKM7:TR?= M2\XXXNCVkeHUh?=
COLO-680N NYPY[YY6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEDFVo5KSzVyPUeuPVE4OyEQvF2= MWjTRW5ITVJ?
HCC1395 Mnq3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{DHUGlEPTB;OD6wOVQ2OiEQvF2= Mn\uV2FPT0WU
NCI-H28 MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUfnfoNEUUN3ME24MlA2QTZ|IN88US=> NU\tXJJtW0GQR1XS
LC-2-ad NX\JU5RFT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH7Yd4FKSzVyPUiuNlE6OzdizszN NUjFSXJFW0GQR1XS
S-117 MkjSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUXEO2dxUUN3ME24MlI2OzV|IN88US=> NH3KPHNUSU6JRWK=
NCI-H1838 NG\ocIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWPJR|UxRThwMkW3PFEh|ryP NEfzU5VUSU6JRWK=
PANC-10-05 NWLZXZVsT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4\NSGlEPTB;OD6zO|A1PyEQvF2= NVj4N2VUW0GQR1XS
KALS-1 MnHBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlrwTWM2OD16LkWwPVI5KM7:TR?= NIfGZVZUSU6JRWK=
LS-1034 MmLLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NWjlWGxNUUN3ME24MlU4PDN5IN88US=> NF;scYFUSU6JRWK=
TGBC1TKB MlzES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M4HRRWlEPTB;OD63N|U{PSEQvF2= NFfmPIlUSU6JRWK=
OE19 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUnPelRqUUN3ME24Mlc3OjZ{IN88US=> M1j2ZXNCVkeHUh?=
D-502MG M1zGeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mn22TWM2OD16Lke2PVk1KM7:TR?= NWPFVmNFW0GQR1XS
JEG-3 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXzYWYVnUUN3ME24Mlc5PjF6IN88US=> MoH4V2FPT0WU
DBTRG-05MG NV;Bdm1UT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYnJR|UxRThwOEe1OlUh|ryP MmLQV2FPT0WU
ME-180 Ml;XS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUDJR|UxRTlwME[3NlUh|ryP MVfTRW5ITVJ?
NCI-H1573 NXO4WVRCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1Pne2lEPTB;OT6xNFU{OiEQvF2= NG\USnhUSU6JRWK=
HCC2998 Moj0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEjxbplKSzVyPUmuNVM3QDFizszN NWfC[Fk3W0GQR1XS
ACHN M4nEVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHXsdY9KSzVyPUmuNlQ6PzVizszN NHHTUI5USU6JRWK=
D-392MG NGDVfoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXjJR|UxRTlwMkW3NVUh|ryP NHf0Z45USU6JRWK=
no-11 M3LyVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHK1cVVKSzVyPUmuNlYxOjhizszN MkTpV2FPT0WU
KLE NV\qXmF5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3PCRWlEPTB;OT6zNlI{OiEQvF2= M{jqfHNCVkeHUh?=
Calu-6 M2my[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MoLsTWM2OD17LkO3OVI5KM7:TR?= NFi1bpdUSU6JRWK=
LB831-BLC MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{Xvb2lEPTB;OT60OVE4OSEQvF2= M1zHUXNCVkeHUh?=
SW684 NFj2TWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MV3JR|UxRTlwNE[xNVYh|ryP MoPOV2FPT0WU
SH-4 MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MnX5TWM2OD17LkS5N|Y1KM7:TR?= MV3TRW5ITVJ?
IST-MES1 M4rBZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NX;ibmt4UUN3ME25MlUyPjR2IN88US=> M{XWOHNCVkeHUh?=
Saos-2 MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MXvJR|UxRTlwNUKxPVUh|ryP NF\u[nhUSU6JRWK=
NCI-H2087 NILqSZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4rzcWlEPTB;OT62O|M2OiEQvF2= MkPhV2FPT0WU
SCC-9 MmWwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXz2fm9OUUN3ME25MlcyQDF4IN88US=> NEjoeIlUSU6JRWK=
MFE-280 NX:5b2NqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFXBOGNKSzVyPUmuO|I4QDVizszN NF7qZWxUSU6JRWK=
BEN MmrTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MnS0TWM2OD17LkiyNVU6KM7:TR?= MlPZV2FPT0WU
CP50-MEL-B MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV7JR|UxRTlwOUK0N|Ih|ryP NFH3PGZUSU6JRWK=
SK-MEL-28 NFnSfHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MUnJR|UxRTFyLkCxPVMh|ryP MYDTRW5ITVJ?
NCI-H2452 NWn6SYV[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYjrfGQyUUN3ME2xNE4yPiEQvF2= NF72OXlUSU6JRWK=
NCI-H1395 NWfUVm5[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4fLTmlEPTB;MUCuNVc5KM7:TR?= M4\ZS3NCVkeHUh?=
NCI-H2052 M17JZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4LrNWlEPTB;MUCuNVg5OiEQvF2= MnTFV2FPT0WU
A375 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MljBTWM2OD1zMD6yOFUzKM7:TR?= MoLCV2FPT0WU
HCC38 MnjTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M2TrTWlEPTB;MUCuN|IzKM7:TR?= NEfDbJVUSU6JRWK=
LK-2 Mn\xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1\Z[GlEPTB;MUCuOFIxQCEQvF2= NEDCT49USU6JRWK=
SF126 M4XmVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1X1cGlEPTB;MUCuOFczPyEQvF2= NH\IfoFUSU6JRWK=
SK-MEL-1 NVP4V5JLT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NULDcmh5UUN3ME2xNE44QDN6IN88US=> MVfTRW5ITVJ?
ACN NInKUnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M2n5dmlEPTB;MUCuPFY4QSEQvF2= MUTTRW5ITVJ?
BB30-HNC MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVfJR|UxRTFyLki3NVEh|ryP Mnf3V2FPT0WU
NCI-H747 NYXwN5pCT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEDLOGhKSzVyPUGwMlg4PDZizszN NGTrPG5USU6JRWK=
KYSE-150 MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MV;JR|UxRTFzLkCzPFch|ryP M{TxdXNCVkeHUh?=
D-247MG NFnnWYFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXPJR|UxRTFzLkGwNFkh|ryP M{LWPXNCVkeHUh?=
BxPC-3 NFGxdodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mkf5TWM2OD1zMT6zO|Q4KM7:TR?= MnnjV2FPT0WU
SK-MEL-30 MmPjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M33hT2lEPTB;MUGuOFA4QSEQvF2= M1rtXnNCVkeHUh?=
CAS-1 NETBeFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{HLNGlEPTB;MUGuOFExQSEQvF2= NHPVU29USU6JRWK=
no-10 NXP6co9PT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWjvcGxwUUN3ME2xNk4yOjF5IN88US=> MofWV2FPT0WU
NCI-H2405 MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NILNWGxKSzVyPUGyMlIxOzZizszN NH3iUplUSU6JRWK=
KGN M{DrdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYPsTlBnUUN3ME2xNk4zQTBzIN88US=> NHfp[lNUSU6JRWK=
BB49-HNC M4fR[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M2LlUGlEPTB;MUKuN|k2PiEQvF2= MkS3V2FPT0WU
NCI-H1693 NETvTJJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVnVTGtuUUN3ME2xNk42QDF4IN88US=> M4jjUHNCVkeHUh?=
RO82-W-1 Mn;yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFvxU5ZKSzVyPUGzMlA3PDlizszN MWPTRW5ITVJ?
CAL-85-1 NGDaeVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MojNTWM2OD1zMz60N|k6KM7:TR?= MWLTRW5ITVJ?
H-EMC-SS NEHDNphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmnuTWM2OD1zMz65NVA1KM7:TR?= MWrTRW5ITVJ?
SW1783 NV2zU3JGT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVvCRmVIUUN3ME2xOE4zOzlzIN88US=> Mn\mV2FPT0WU
LB771-HNC M3;IeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MVrJR|UxRTF2LkSxPUDPxE1? NF;KTZdUSU6JRWK=
HCC70 M3q1Umdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NEH2eIJKSzVyPUG0MlQzOzNizszN MWnTRW5ITVJ?
KNS-81-FD MoL2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHTRb2tKSzVyPUG0MlcxPDVizszN MYjTRW5ITVJ?
KYSE-520 Mli4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NEPnbVlKSzVyPUG0MlkzPyEQvF2= Ml6xV2FPT0WU
TGBC24TKB M13tUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYeyW2g3UUN3ME2xOE46PTN7IN88US=> NHrKclJUSU6JRWK=
SNB75 NHXTPVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NX;icoluUUN3ME2xOU4xPzJ7IN88US=> M4n6NXNCVkeHUh?=
SW872 NWO3XldnT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHPq[VhKSzVyPUG1MlIzOThizszN NGrkRXpUSU6JRWK=
U031 NWG5ZoxST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3z0OGlEPTB;MUWuPFAzQCEQvF2= NHzPNXNUSU6JRWK=
ChaGo-K-1 MnP0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXHJR|UxRTF3LkizOVkh|ryP NXjye5dJW0GQR1XS
NCI-H441 MnLWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFPYWZhKSzVyPUG2MlAxOzlizszN M1m5NHNCVkeHUh?=
TE-12 M4W3Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NHzYWYNKSzVyPUG2MlE5PzNizszN M1q3d3NCVkeHUh?=
NCI-H1755 NH3OcG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{SycGlEPTB;MU[uOVc{KM7:TR?= MXLTRW5ITVJ?
KNS-42 MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4f1[2lEPTB;MU[uOlU5QSEQvF2= Ml\1V2FPT0WU
SK-PN-DW NWD5SVhXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M3PBNWlEPTB;MUeuOFIxOSEQvF2= NF3nTJhUSU6JRWK=
NCI-H226 MlvqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXe3WIpIUUN3ME2xO{46OzR3IN88US=> MnTSV2FPT0WU
K-562 NILRemVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVHUVGxZUUN3ME2xPE43OzF5IN88US=> M3LqPHNCVkeHUh?=
A388 NW\KfWExT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NEK2TIpKSzVyPUG5MlA{ODNizszN MXLTRW5ITVJ?
ZR-75-30 M4fQTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mke2TWM2OD1zOT6wPVY5KM7:TR?= NXjTXIdHW0GQR1XS
LU-135 NGjyZmpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MlzmTWM2OD1zOT6yOlM3KM7:TR?= MmnhV2FPT0WU
NCI-H2029 NVLTOWExT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Ml3vTWM2OD1zOT62NFIyKM7:TR?= MWHTRW5ITVJ?
HT-1197 NEK5fVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH2wR4hKSzVyPUG5MlkzOjdizszN MVLTRW5ITVJ?
IGR-1 MlvWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlLITWM2OD1{MD6zNVE4KM7:TR?= M164Z3NCVkeHUh?=
U-87-MG NU\2cmdOT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= Mm\UTWM2OD1{MD62OFE{KM7:TR?= NXjmT3NVW0GQR1XS
NCI-H1304 NUTX[XRKT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUXTeIs6UUN3ME2yNE44PTBzIN88US=> M4TJd3NCVkeHUh?=
RCC10RGB M4\pemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV\GXJpRUUN3ME2yNU4zQDJ7IN88US=> Mnv4V2FPT0WU
NCI-H520 MlvsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{DFRmlEPTB;MkKuO|YyOSEQvF2= MVzTRW5ITVJ?
SK-LU-1 NFP6eZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1z4dGlEPTB;MkOuNFcyQCEQvF2= NXTD[m01W0GQR1XS
UACC-893 MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NYm5fHVkUUN3ME2yN{4yODN6IN88US=> Ml;SV2FPT0WU
NCI-H2347 M3rsTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWTJR|UxRTJ|LkK2O|Qh|ryP M2f4RXNCVkeHUh?=
U-118-MG NELETZlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NYjCdWJqUUN3ME2yN{44OjF5IN88US=> NHvsZYtUSU6JRWK=
NCI-H596 M3;XOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYDnNpJwUUN3ME2yN{46ODV3IN88US=> NFX3cJhUSU6JRWK=
MZ1-PC NUT4W|Y5T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NYfpb2RlUUN3ME2yOE43PzV7IN88US=> MU\TRW5ITVJ?
SW1417 NXvWenQzT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIrIOVNKSzVyPUK1MlI1QThizszN MYnTRW5ITVJ?
NCI-H82 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MVHJR|UxRTJ4LkSyPFgh|ryP NUXUemtiW0GQR1XS
COLO-678 NHXCZXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NI\BU5ZKSzVyPUK3MlQ6OTlizszN NIPVSIlUSU6JRWK=
KURAMOCHI MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX7JR|UxRTJ6LkGyOkDPxE1? NHTrW4NUSU6JRWK=
NCI-H1650 M3LoVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1;MSmlEPTB;M{CuNVkzPCEQvF2= M3\rbnNCVkeHUh?=
HCC1954 NWXLVZZjT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWXHUlhzUUN3ME2zNU4{PjZ4IN88US=> MW\TRW5ITVJ?
GAK MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn3ITWM2OD1|Mj6yOlE3KM7:TR?= NHK3foJUSU6JRWK=
YAPC NYLCd3dQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MoqyTWM2OD1|Mz63OlQ5KM7:TR?= M4XyTnNCVkeHUh?=
NCI-H2228 NHfBU5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVLuN5RCUUN3ME2zOE4{PjB3IN88US=> NFHQNIpUSU6JRWK=
VMRC-RCZ NGn0bGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIrJW5dKSzVyPUO2MlMxOjJizszN NGjCSHlUSU6JRWK=
NMC-G1 MnzjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVvJR|UxRTN5LkC1Nlkh|ryP M4CwOnNCVkeHUh?=
D-336MG NYrCNnFRT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NXLwbHRWUUN3ME20NU45PDR{IN88US=> MofTV2FPT0WU
UACC-62 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUW1PFNbUUN3ME20Nk42PTB3IN88US=> M2\VO3NCVkeHUh?=
C-33-A NUjUOYk3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NIDqNmtKSzVyPUS1MlMzPTZizszN MmPMV2FPT0WU
HCC1937 NV\tenB2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NV;vd|ZsUUN3ME20O{4yQTV6IN88US=> NVj4T497W0GQR1XS
HDLM-2 NIXacmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MX;JR|UxRTR5LkKyPFch|ryP Mk\pV2FPT0WU
NCI-H727 NI\wTmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MVTJR|UxRTR5LkK0OVEh|ryP M{fvWnNCVkeHUh?=
NY M1;6cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXnJR|UxRTR7LkO5NFgh|ryP M1PR[3NCVkeHUh?=
NCI-H2291 NGjmOYNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWXJR|UxRTR7LkizNFEh|ryP NXrReZE4W0GQR1XS

... Click to View More Cell Line Experimental Data
Assay
Methods Test Index PMID
Western blot
Ac-Histone H4/Ac-Histone H3; 

PubMed: 21598070     


D54 and U87 glioma cells were treated with lower concentrations (1-3 µM) of vorinostat. The effects on histone acetylation was assessed by immunoblotting. 

phospho-CDK1; 

PubMed: 21598070     


Changes in level of inhibitory phosphorylation of cdk1 after treatment with vorinostat was determined at 24 and 48 h (using a Tyr-15 residue phospho-specific antibody) along with total cdk1 as loading control. 

phospho-Cdc25c/Cdc25c; 

PubMed: 21598070     


Time course of changes in phospho-cdc25c levels after exposure to vorinostat (5 µM).

Cyclin B1; 

PubMed: 21598070     


Cyclin B1 levels were determined in D54 and U87 cells after treatment with various doses of vorinostat at 24 and 48 h.

c-Myc/c-Raf/Akt/Cyclin D1/CDK4; 

PubMed: 19440035     


Cell lysates from JeKo-1 and Mo2058 cells exposed to vorinostat  were immunoblotted for c-Myc, c-Raf, AKT, cyclin D1, CDK4 and acetylated histone H3. The levels of β-actin served as the loading control.

p-eIF2α/ATF4/CHOP ; 

PubMed: 20072656     


Western blot was performed to evaluate activated eIF2α (P-eIF2α), translational up-regulation of ATF4, and CHOP expression in U251 cells after vorinostat exposure.

p21; 

PubMed: 21598070     


To determine the dose response relationship to vorinostat, cells were exposed to various higher concentrations (5–10 µM) of the agent and the levels of p21 determined by immunoblotting.

21598070 19440035 20072656
Immunofluorescence
HDAC1/CK19; 

PubMed: 29917299     


Immunocytochemistry to detect the expression of HDAC1 and CK 19 in PDAC cells with/without Vorinostat treatment. HDAC1 and CK19 were stained red and green, respectively. The Hoechst‐stained nuclei appear blue. Scale bar: 100 μm. The CK19 expression in PSN1 and MiaPaCa2 was increased by Vorinostat treatment.

Nrf2; 

PubMed: 20566897     


Vorinostat induced translocation of Nrf2 from cytosol to nucleus. U937 cells were treated with 2μM vorinostat for 18 hours and then cytospun. Cells were fixed and labeled for Nrf2 protein (red) and nucleus (blue, 4,6-diamidino-2-phenylindole) as described in “Immunofluorescence and confocal microscopy.” Images were taken by Nikon Eclipse TE2000 confocal microscope with 40×/1.30 numeric aperture oil objective lens. Ctrl indicates control cells without treatment; and Vor, vorinostat.

α-SMA; 

PubMed: 26330748     


Representative immunofluorescence images and the quantification graph showing the effect of vorinostat (2.5 µM), TGIF1, and TGIF2 siRNA knockdown on αSMA. Control human corneal fibroblast cultures (-TGFβ) showed no αSMA staining. Cultures treated with TGFβ1 (5 ng/ml) showed a robust αSMA staining. Vorinostat treatment markedly attenuated TGFβ-evoked αSMA staining. The knockdown of TGIF1 (+TGFβ+vorinostat+TGIF1siRNA) and TGIF2 alone (+TGFβ+vorinostat+TGIF2siRNA) or in combination (+TGFβ +vorinostat +TGIF1 +2siRNA) markedly blocked the effect of vorinostat on αSMA. Scale bar=100 μm.

Ac-STAT3/IGF2; 

PubMed: 27086926     


Immunofluorescence staining of Ac-STAT3 and IGF2 after vorinostat treatment.

29917299 20566897 26330748 27086926
Growth inhibition assay
Cell apoptosis; 

PubMed: 19440035     


Cells were treated with indicated concentrations of vorinostat for 48 hours. Following this, the percentage of annexin-V-stained apoptotic cells was determined by flow cytometry. Values represented as bar graphs are the mean of 3 experiments plus or minus the standard error (SE)

Cell viability; 

PubMed: 27086926     


The effects of vorinostat on the viability of the indicated NSCLC cell lines and their corresponding acquired VoR sublines. Cell viability was determined by the MTT assay (n = 3).

19440035 27086926
ELISA
IGF2; 

PubMed: 27086926     


Determination of vorinostat-induced IGF2 production by ELISA (n = 3). The conditioned mediums (CMs) obtained from cells treated with vorinostat (5 μM) for 2 days were used for ELISA. 

IL-13/IL-10/IL-5; 

PubMed: 18541724     


Effect of vorinostat on TH1/TH2 cytokine secretion in HL cell lines. Cells were incubated with medium or vorinostat (5 μM) for 24 hours and supernatants were examined for cytokine levels by ELISA. Each value represents a mean of 3 independent experiments done in triplicate (± SEM).

M-CSF; 

PubMed: 23042302     


Primary PyMT tumor cells were treated with SAHA (0-1000nM) for varying time points (8–48h), and supernatants were assayed by ELISA for M-CSF  secretion. *P < 0.05 and **P < 0.001 versus control treatment. 

MMP-9; 

PubMed: 23042302     


Primary PyMT tumor cells were treated with SAHA (0-1000nM) for varying time points (8–48h), and supernatants were assayed by ELISA for MMP-9 secretion. *P < 0.05 and **P < 0.001 versus control treatment. 

27086926 18541724 23042302
体内研究 Decitabine和Vorinostat都具有使肿瘤衰退的功能。然而, Decitabine 和 Vorinostat 联用使肿瘤衰退的效果更强。没有任何处理时,在野生型和Fasgld 小鼠中在肺肿瘤负担方面观察不到明显的区别。然而, Decitabine 和Vorinostat联用处理野生型小鼠，使肿瘤衰退比处理 Fasgld小鼠效果高很多。 Decitabine和Vorinostat使结肠癌细胞对FasL调节的肿瘤衰退敏感。低剂量Decitabine和Vorinostat处理，没有明显的肝脏毒性。[3]

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

激酶实验：[4]
+ 展开

组蛋白去乙酰化酶活性测定:

为了进行 HDAC 实验24 × 104 dpm 乙醇溶液(1 mCi/ml)中提供的sup>3H-醋酸钠盐标记的组蛋白H4等份样, 加到每个试管中，试管中含悬浮在25 µL实验buffer(100 mM Tris-HCl pH 8, 2mM EDTA)中的200 µg全部HeLa细胞裂解液进行免疫沉淀获得的HDAC。加入不同浓度Vorinostat，在30oC下温育90分钟。加入20 µL 终止缓冲液(0.5 N HCl, 0.08 M AcOH)终止反应。加入0.8 mL TBME提取释放放入氚醋酸盐。在8,000 × g 转速下离心5分钟，600 µL 有机相(上相) 转移到包含3 mL闪烁液的闪烁瓶中。
细胞实验：[4]
+ 展开
  • Cell lines: NB4, NCI-H460和HCT-116肿瘤细胞系
  • Concentrations: 0 μM - 0.1 μM
  • Incubation Time: 48小时
  • Method: NB4, NCI-H460和HCT-116肿瘤细胞系生长在200 µL 96孔板中，约10%汇合，生长24小时后，覆盖孔中。使用多种浓度 Vorinostat或溶剂处理肿瘤细胞24小时。处理后，冲洗实验板，移除Vorinostat，温育48小时。使用sulphorodamine B 实验测定Vorinostat处理后存活细胞的分数。
    (Only for Reference)
动物实验：[3]
+ 展开
  • Animal Models: 携带CT26 细胞的Fasgld BALB/cByJ小鼠
  • Formulation: Dissolved in DMSO
  • Dosages: 25 mg/kg
  • Administration: 静脉注射
    (Only for Reference)

溶解度 (25°C)

体外 DMSO 52 mg/mL (196.74 mM)
Ethanol 3 mg/mL (11.35 mM)
Water Insoluble
体内 从左到右依次将纯溶剂加入产品，现配现用(数据来自Selleck实验检测而非文献)：
2% DMSO+30% PEG 300+5% Tween 80+ddH2O 		5mg/mL

* 溶解度检测是由Selleck技术部门检测的，可能会和文献中提供的溶解度有所差异，这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据

分子量 264.3
化学式

C14H20N2O3
CAS号 149647-78-9
稳定性 powder
in solvent
别名 SAHA, MK0683, suberoylanilide hydroxamic acid

计算器

摩尔浓度计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系，公式为:

质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • 质量
    浓度
    体积
    分子量

*在配置溶液时，请务必参考Selleck产品标签上、MSDS / COA（可在Selleck的产品页面获得）批次特异的分子量使用本工具。

稀释计算器

稀释计算器

用本工具协助配置特定浓度的溶液，使用的计算公式为：

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入 输出 )

  • C1
    V1
    C2
    V2